SlideShare una empresa de Scribd logo
1 de 116
Descargar para leer sin conexión
MR. JAYESH PATIDAR
www.drjayeshpatidar.blogspot.com
INTRODUCTION…
• Psychopharmacology is the study of
drugs used to treat psychiatric disorders.
• Medications that affect psychic function,
behavior or experience are called
psychotropic medications.
• They have significant effect on higher
mental functions.
• Psychopharmacological agents are first
line treatment for almost all psychiatric
ailments now a days.
4/24/2013 2JAYESH PATIDAR
Count…
• With the growing availability of a wide
range of drugs to treat mental illness, the
nurse practicing in modern psychiatric
settings needs to have a sound
knowledge of the pharmacokinetics
involved, the benefits & potential risks of
pharmacotherapy, as well as her own
role & responsibility.
4/24/2013 3JAYESH PATIDAR
DEFINITION OF PSYCHOTROPIC
DRUGS
Psychotropic drug is any drug
that has primary effects on behavior,
experience, or other psychological functions
(Logman Dictionary of Psychology &
Psychiatry). Psychotropic or psychoactive
drugs can also be defined as chemical that
affects the brain & nervous system, alter
feelings & emotions. These drugs also affect
the consciousness in various ways. A broad
range of these drugs is used in emotional &
mental illnesses.
4/24/2013 4JAYESH PATIDAR
GENERAL GUIDELINES REGARDING
DRUG ADMINISTRATION IN PSYCHIATRY
• The nurse should not administer any drug unless
there is a written order. Do not hesitate to consult
the doctor when in doubt any medication.
• All medications given must be charted on the
patient‘s case record sheet.
• In giving medication:
– Always address the patient by name & make certain of
his identification.
– Do not leave the patient until the drug is swallowed.
– Do not permit the patient to go to the bathroom to take
medication.
– Do not allow one patient to carry medicine to another.
4/24/2013 5
JAYESHPATIDAR
Count…
• If it is necessary to leave the patient to get
water, do not leave the tray within the reach of
the patient.
• Do not force oral medication because of the
danger of aspiration. This is especially
important in stuporous patients.
• Check drugs daily for any change in color, odor
& number.
• Bottle should be tightly closed & labeled. Labels
should be written legibly & in bold lettering.
Poison drugs are to be legibly labeled & to be
kept in separate cupboard.
4/24/2013 6JAYESH PATIDAR
Count…
• Make sure that an adequate supply of drugs
is on hand, but do not overstock.
• Make sure no patient has access to the drug
cupboard.
• Drug cupboard should always be kept
locked when not in use. Never allow a
patient or worker to clean the drug
cupboard. The drug cupboard keys should
not be given to patients.
4/24/2013 7JAYESH PATIDAR
PATIENT EDUCATION RELATED TO
PSYCHOPHARMACOLOGY…
• Nurses assess for drug side effects, evaluate
desired effects, & make decisions about prn
(pro re neta) medication.
• Nurses must understand general principles of
psychopharmacology & have specific
knowledge related to psychotropic drugs.
• Teaching patients can decrease the incidence
of side effects while increasing compliance
with the drug regimen.
4/24/2013 8JAYESH PATIDAR
Specific areas of education include
the following…
1. Discussion of side effects: Side effects can
directly affect the patient‘s willingness to
adhere to the drug regimen. The nurse should
always inquire about the patient‘s response to
a drug, both therapeutic responses & adverse
responses
2. Drug interactions: Patients & families must
be taught to discuss the effects of the addition
of over-the-counter drugs, alcohol & illegal
drugs to currently prescribed drugs.
4/24/2013 9JAYESH PATIDAR
Count…
3. Discussion of safety issues: Because some
drugs, such as tricyclic antidepressants, have a
narrow therapeutic index, thoughts of self harm
must be discussed.
• Discuss on abruptly discontinued effects.
• Many psychotropic drugs cause sedation or
drowsiness, discussions concerning use of
hazardous machinery, driving must be reviewed
4. Instructions for older adult patients: Because
older individuals have a different
pharmacokinetic profile than younger adults,
special instructions concerning side effects &
drug-drug interactions should be explained.
4/24/2013 10
JAYESH PATIDAR
Count…
5. Instructions for pregnant or breastfeeding
patient: As pregnant or breastfeeding patients
have special risks associated with
psychotropic drug therapy, special
instructions should be tailored for these
individuals. Teaching patients about their
medications enables them to be mature
participants in their own care & decreases
undesirable side effects
4/24/2013 11JAYESH PATIDAR
CLASSIFICATIONS OF PSYCHOTROPIC
DRUGS
1. Antipsychotic agents
2. Antidepressant agents
3. Mood stabilizing drug
4. Anxiolytics & hypnosedatives
5. Antiepileptic drug
6. Antiparkinsonian drugs
7. Miscellaneous drugs which include stimulants,
drugs used in eating disorders, drugs used in
deaddiction, drugs uses in child psychiatry,
vitamins, calcium channel blockers etc.
4/24/2013 12JAYESH PATIDAR
ANTIPSYCHOTIC
AGENTS
4/24/2013 13JAYESH PATIDAR
DESCRIPTION:-
• Antipsychotic agents are also known as
neuroleptic, major tranquillizers, or
phenothaiazines.
• This group of drugs has a major clinical
use in the treatment of psychosis.
• Psychosis is a state in which a person‘s
ability to recognize reality to
communicate & to relate to others is
severely impaired.
4/24/2013 14JAYESH PATIDAR
MODE OF ACTION:-
• Antipsychotic agents are thought to block the
dopamine receptors.
• Dopamine is a chemical which is released in
the brain & causes psychotic thinking.
• Increased production of dopamine transmits the
nerve impulses to the brainstem faster than
normal. This result in strange thoughts ,
hallucination & bizarre behavior.
• Antipsychotics helps in blocking or reducing the
activity of dopamine.
• Antiemetic is another property of antipsychotic
agents. They are also used in hiccoughs.
4/24/2013 15JAYESH PATIDAR
Class Examples of
drugs
Trade name Oral dose
mg/day
Parenteral
dose (mg)
Phenothiazines Chlorpromazine
Triflupromazine
Thioridazine
Trifluoperazine
Fluphenazine
decanoate
Megatil
Largactil
Tranchlor
Siquil
Thioril, Melleril
Ridazin
Espazine
prolinate
300-1500
100-400
300-800
15-60
-
50-100 IM
only
30-60 IM only
1-5 IM
25-50 IM
every 1-3
weeks.
Thioxanthenes flupenthixol fluanxol 3-40
CLASSIFICATION:-
4/24/2013 16JAYESH PATIDAR
Class Examples of
drugs
Trade name Oral dose
mg/day
Parenteral
dose (mg)
Diphenylbutyl Pimozide orap 4-20
piperidines penfluridol flumap 20-60 weekly -
Indolic
derivatives
molindone mobam 50-225 -
Dibenzoxazepines loxapine loxapac 25-100 -
Atypical
antipsychotics
Clozapine
Risperidone
Olanzapine
Quetiapine
Ziprasidone
Sizopine, Lozapin
Sizodon, sizomax
Oleanz
Qutan
Zisper
50-450
2-10
10-20
150-750 mg
20-80 mg
Others reserpine serpasil 0.5-50
Count…
4/24/2013 17JAYESH PATIDAR
INDICATIONS
 Organic psychiatric
disorders:
• Delirium
• Dementia
• Delirium tremens
• Drug-induced psychosis &
other organic mental
disorders
 Functional disorders:
• Schizophrenia
• Schizoaffective disorders
• Paranoid disorders
 Mood disorders:
• Mania
• Major depression with
psychotic symptoms
 Childhood disorders:
• Attention-deficit
hyperactivity disorder
• Autism
• Enuresis
• Conduct disorder
4/24/2013 JAYESH PATIDAR 18
Count…
 Neurotic & other
psychiatric disorders:
• Anorexia nervosa
• Intractable obsessive-
compulsive disorder
• Severe, intractable &
disabling anxiety
 Medical disorders:
• Huntington‘s chorea
• Intractable hiccough
• Nausea & vomiting
• Tic disorder
• Eclampsia
• Heart stroke severe
pain in malignancy
tetanus
4/24/2013 JAYESH PATIDAR 19
PHARMACOKINETICS
• Antipsychotics when administered orally are absorbed
variably from the gastrointestinal tract, with uneven
blood levels.
• They are highly bound to plasma as well as tissue
proteins. Brain concentration is higher than the
plasma concentration.
• They are metabolized in the liver, & excreted mainly
through the kidneys. The elimination half-life varies
from 10 to 24 hours.
• Most of the antipsychotics tend to have a therapeutic
window. If the blood level is below this window, the
drug is ineffective. If the blood level is higher than the
upper limit of the window, there is toxicity or the drug
is again ineffective.
4/24/2013 JAYESH PATIDAR 20
SIDE-EFFECTS
1) Extrapyramidal symptoms (EPS)
i. Neuroleptic-induced parkinsonism:- occur
in 40% of the patients presenting
extrapyramidal symptoms. There are two
varieties of parkinsonia symptoms:
a. Akinetic Form:- Appears in the first week
of administration of antipsychotic drugs.
The characteristics of akinetic form are:
Difficulty in masticating movements,
weakness & muscle fatigue.
4/24/2013 JAYESH PATIDAR 21
Count…
b. Agitating Form of parkinsonian Symptoms
include:- Tremors at rest, rigidity & mask-like
face. Most characteristic features of parkinsonism
are:-
Rigidity of muscles
Motor retardation
salivation
slurred speech
mask-like face
shuffling gait
Anticholinergi drugs are given as treatments.
4/24/2013 JAYESH PATIDAR 22
Count…
ii. Akathisia:-
Akathisia occurs in 50% of
all the patients presenting
extrapyrimidal symptoms. The common
characteristics: Restless ―walking in
place‖. Difficulty in sitting still, or strong
urge to move about- referred to as
―Walkies & Talkies‖ by haris . generally
occurs after two weeks of treatment.
Before administering anti-parkinsonian
medication anxiety should be ruled out.
4/24/2013 JAYESH PATIDAR 23
Count…
iii. Dystonia:-
Dystonia occurs in 6% of total number
of patient‘s presenting EPS. The characteristic
features are: rapidly developing contraction of
muscles of the tongue, jaw, neck (producing
torticollis) & etraocular muscles. Combined
torticolis & extraocular spasm results in an
oculogyric crisis in which eyes looked upward,
head is turned to one side. Dystonia is painful
& gives a frightening experience to the patient.
Constant observation of the patient should be
made. Dystonia occurs within a few minutes of
giving medicine or after several hours.
4/24/2013 JAYESH PATIDAR 24
Count…
iv. Tardive Dyskinesia:-
This occur due to abrupt
termination or reduction of the antipsychotic
drug after long-term-high-dose therapy.
Tardive dyskinesia is characterized by
involuntary rhythmic, stereotyped movements,
protrusion of the tongue, puffing of cheeks,
chewing movements, involuntary movements
of extremities & trunk. These symptoms occur
in 3% of patients. Antipsychotics should be
stoped immediately. There is no treatment,
symptoms may appear for years. It is
irreversible.
4/24/2013 JAYESH PATIDAR 25
Count…
V. Neuroleptic Malignant Syndrome (NMS):-
This is a rare
complication of antipsychotic agents & is
usually fetal. Many develop within hours or
after years of continued drug use. Symptoms
include hyperpyrexia, severe muscle rigidity,
altered consciousness, blood pressure
changes, increased count of W.B.C.
symptoms appear suddenly when medication
is started & can persist for 10-14 days or
longer. Symptomatic treatment is given to
patients.
4/24/2013 JAYESH PATIDAR 26
Count…
2) Autonomic Nervous System:-
Dry mouth, blurred vision,
constipation, urinary hesitance or retention & under
rare circumstances paralytic ileus.
3) Cardio-Vascular:-
Tachycardia, orthostatic hypotension &
reversible arrhythmias.
4) Blood or Hematopoietic:-
Agrunulocytosis (marked decrease in
leukocytes system especially with chlorpramozine)
leucopenia, leukocytosis.
4/24/2013 JAYESH PATIDAR 27
Count…
5) Endocrine Disruptions:-
Menstrual irregularities, including
amenorrhea & false positive pregnancy tests, breast
enlargement, lactation, weight gain, changes in libido,
impotence, glycosuria, hyperglycemia.
6) Gastro-Intestinal:-
Anorexia, constipation, diarrhea, hypersalivation,
nausea, vomiting, obstructive jaundice.
7) Allergic effects:-
Dermatitis, photosensitization, pigment
deposits.
4/24/2013 JAYESH PATIDAR 28
Count…
8) Occular Effcts:-
Blurring of vision, pigmentation of
cornea & lens & retinopathy.
9) Hepatic Side-effects:-
Liver toxicity occurs in 0.5% of cases
presenting EPS. It is a hypersensitivity reaction &
dose dependent. Onset of symptoms is within the
first one month of treatment. Symptoms may be
fever, chills, nausea, malaise, prurites & jaundice.
4/24/2013 JAYESH PATIDAR 29
NURSE’S RESPONCIBILITY
 Close observation, especially when the antipsychotic are
just started. The expected results are reduction in
aggressive hyperactive behavior & disorganized thoughts.
Look for the possible side-effects.
 Extrapyramidal reaction, i.e. Parkinsonism, akinesia,
akathisia, dystonia, & tardive dyskinesia. These symptoms
are reduced/treated with early observation, reporting &
use of anti-parkinsonion or anticholinergic medication.
 Observe drowsiness. Medicine should be administered at
bed time. Report if the drowsiness persists for a very long
time. The patient should be advised not to drive & handle
hazardous machinery while taking antipsychotic drugs.
Observe for sore throat, fever due to agranulocytosis.
4/24/2013 JAYESH PATIDAR 30
Count…
 Record blood pressure of the patient on
antipsychotic drugs. If the BP is drops by 20 to30
mm of hg in the patient, immediate reporting &
intervention should be done. The patient should be
made aware of the possibility of dizziness & injuries
after receiving medication & injection due to
orthostatic hypotension.
 Accurate rout of medication- antipsychotic drugs are
not given subcutaneously unless specially prescribed
as they cause tissue irritation. These drugs should
be given deep IM.
 Dry mouth may be may be reduced by encouraging
the patient to rinse his or her mouth frequently. Give
a piece of lemon or chewing gum. Good oral hygiene
should also be maintained.
4/24/2013 JAYESH PATIDAR 31
Count…
 Blurred or impaired vision in the patient causes anxiety
& annonyance to him. The patient should be
encouraged to inform these symptoms immediately.
Blurred vision or brown coloured vision, night blindness
can be permanent due to pigmentary retinopathy.
 The patient on antipsychotic drugs may have weight
gain. Weight record should be maintained. The patient
may be encouraged on a low salt & planned caloric diet.
 The patient may complain of gastric irritation. He should
be discouraged to take antacid as there will be
decreased absorption of antipsychotic drugs.
 An intake output chart should be maintained specially
for male patients who are confined to bed & have an
enlarged prostate gland. Encourage at least 2500 ml of
liquid intake.
4/24/2013 JAYESH PATIDAR 32
Count…
 The patient should be advised to protect his skin, by not going
in the sun & to wear protective clothing & sunglasses.
 The patient should be explained not to increase or decrease
or stop taking drugs without discussing with his doctor. The
drugs should be withdrawn slowly to avoid nausea or
seizures.
 The nurse should find out menstrual changes from the female
patient. Sometimes the patient may complain of fever, upper
abdominal pain, nausea, jaundice & diarrhea. These
symptoms can be due to cholestatic jaundice. The nurse
should stop the medicine immediately & inform the doctor.
 Reassurance to relatives- The patient & his relatives should
be explained that desired effects will be achieved after weeks
of medication, so the relatives need to wait for the effects of
the drugs.
4/24/2013 JAYESH PATIDAR 33
ANTIDEPRESSANTS
AGENTS
4/24/2013 JAYESH PATIDAR 34
DESCRIPTION
• Antidepressant agents are used in
affective disorders or disturbances
mainly to treat depressive disorders
caused by emotional or environmental
stressors.
• Several groups of affective
disturbances are treatable by
antidepressants.
4/24/2013 JAYESH PATIDAR 35
MODE OF ACTION
• Antidepressant drugs are classified as Tricyclics,
Tetracyclics & MAO inhibitors. Research studies
have shown reduced levels of norepinephrine (NE) &
serotonin (5-HT) in the space between nerve ending
carrying message from one nerve cell to another
cause depression.
• Tricyclic antidepressants & MAO inhibitors increase
these neurotransmitters i.e. norepinephrine & sertinin
to the synaptic receptors in the central nervous
system. Tricyclic inhibitors block the reuptake of NE
& 5-HT & MAO inhibitors block the action of
MONOamine oxidize in breaking down excess of NE
& 5-HT at the presynaptic neuron.
4/24/2013 JAYESH PATIDAR 36
CLASSIFICATION
CLASS EXAMPLES OF
DRUGS
TRADE NAME ORAL DOSE
(mg/day)
Tricyclic
antidepressants (TCAs)
Imipramine
Amitriptyline
Clomipramine
Dothiepin
mianserin
Antidep
Tryptomer
Anafranil
Prothiaden
depnon
75-300
75-300
75-300
75-300
30-120
Selective serotonin
reuptake inhibitors
(SSRIs)
Fluoxetine
Sertraline
Fludac
Serenata
10-80
50-200
Dopaminergic
antidepressants
fluvoxamine faverin 50-300
Atypical
antidepressants
amineptine survector 100-400
Monoamine oxidase
inhibitors (MAOIs)
Trazodone
isocarboxazid
Trazalon
Marplan
150-600
10-304/24/2013 JAYESH PATIDAR 37
INDICATIONS
 Depression
• Depressive episode
• Dysthymia
• Reactive depression
• Secondary depression
• Abnormal grief reaction
 Childhood psychiatric
disorders
• Enuresis
• Separation anxiety disorder
• Somnambulism
• School phobia
• Night terrors
 Other psychiatric disorders
• Panic attack
• Generalized anxiety disorder
• Agrophobia, social phobia
• OCD with or without depression
• Eating disorder
• Borderline personality disorder
• Post-traumatic stress disorder
• Depersonalization syndrome
 Medical disorder
• Chronic pain
• Migraine
• Peptic ulcer disease
4/24/2013 JAYESH PATIDAR 38
PHARMACOKINETICS
• Antidepressants are highly
lipophilic & protein-bound. The
half-life is long & usually more
than 24 hours.
• It is predominantly metabolized in
the liver.
4/24/2013 JAYESH PATIDAR 39
CONTRAINDICATION
• Antidepressants are given with caution
to patients with cardiovascular disorder
because they cause arrhythmias.
• They increase symptoms of psychosis
& mania in cases of manic-depressive
psychosis.
• Drugs are given with caution to
prevents with liver disorders.
4/24/2013 JAYESH PATIDAR 40
SIDE EFFECTS
1) Autonomic side-effects:
Dry mouth, constipation,
cycloplegia, mydriasis, urinary retention, orthostatic
hypotension, impotence, impaired ejaculation,
delirium & aggravation of glaucoma.
2) CNS effects:-
Sedation, tremor & other extrapyramidal
symptoms, withdrawal syndrome, seizures,
jitteriness syndrome, precipitation of mania.
3) Cardiac side-effects:-
Tachycardia, ECG changes, arrhythmias,
direct myocardial depression, quinidine-like
action(decreased conduction time).
4/24/2013 JAYESH PATIDAR 41
Count…
4) Allergic side-effects:-
Agranulocytosis, cholestatic
jaundice, skin rashes, systemic vasculitis.
5) Metabolic & endocrine side-effects:-
weight gain
6) Special effects of MAOI drugs:-
Hypertensive crises, severe
hepatic necrosis, hyperpyrexia.
4/24/2013 JAYESH PATIDAR 42
NURSE’S RESPONSIBILITY
 Observation of the side-effects & monitoring the
changes noted are very significant to prevent
complications due to antidepressant agents.
 Encourage the patient to take medicine at bed
time due to a sedative effect. Dryness of mouth to
decrease.
 Give plenty of fluids orally. Lemonade or chewing
gum should be given. A few sips of water also
help the patient.
 Do not give medicine empty stomach as the
patient complains of nausea & vomiting.
4/24/2013 JAYESH PATIDAR 43
Count…
 Accurate recording of intake & output of the patient
should be maintained to check if he has retention of
urine.
 If the patient complains of dizziness or light headedness
he/she should be encouraged to get up slowly & sit in the
bed before standing. These symptoms may due to
orthostatic hypotension. The patient should be reassured
that these symptoms are for a short period only. Some
patients may present hypertension.
 Accurate recording of vital signs like B.P. & pulse.
 The nurse should be able to interpret the blood reports
specially blood sugar level & W.B.C. count. If the patient
complains of sore throat, fever, malaise, it should be
reported to the physician on duty. These symptoms may
be due to agranulocytosis or hyperglycemia.
4/24/2013 JAYESH PATIDAR 44
Count…
 To relieve constipation plenty of fluids &
roughage should be encouraged in the diet.
 If the patient complains of sexual dysfunction
inform the physician immediately & stop the
drug.
 If the patient is presenting symptoms of
pressure of speech, increased motor activity &
elated mood, the physician should be informed
& the drug should be stopped immediately.
 Antidepressant tricyclic drugs begin
therapeutic effects within four to eight weeks.
 Accurate recording of the observation made.
4/24/2013 JAYESH PATIDAR 45
MOOD
STABILIZING
DRUGS
4/24/2013 JAYESH PATIDAR 46
Mood stabilizers are
used for the treatment of bipolar
affective disorders. Some commonly
used mood stabilizers are:-
1. Lithium
2. Carbamazepine
3. Sodium Valproate
4/24/2013 JAYESH PATIDAR 47
LITHIUM
4/24/2013 JAYESH PATIDAR 48
DESCRIPTION
• Lithium is an element with atomic
number 3 & atomic weight 7.
• It was discovered by FJ Cade in
1949, & is a most effective &
commonly used drug in the
treatment of mania.
4/24/2013 JAYESH PATIDAR 49
MODE OF ACTION
The probable mechanisms of action can be:
• It accelerates presynaptic re-uptake &
destruction of catecholamines, like
norepinephrine.
• It inhibits the release of catecholamines at the
synapse.
• It decreases postsynaptic serotonin receptor
sensitivity.
All these actions result in decreased
catecholamine activity, thus ameliorating
mania.
4/24/2013 JAYESH PATIDAR 50
INDICATION
 Acute mania
 Prophylaxis for
bipolar & unipolar
mood disorder.
 Schizoaffective
disorder
 Cyclothymia
 Impulsivity &
aggression
Other disorders:
– Premenstrual
dysphoric disorder
– Bulimia nervosa
– Borderline
personality disorder
– Episodes of binge
drinking
– Trichotillomania
– Cluster headaches
4/24/2013 JAYESH PATIDAR 51
PHARMACOKINETICS
• Lithium is readily absorbed with peak plasma
levels occurring 2-4 hours after a single oral
dose of lithium carbonate.
• Lithium is distributed rapidly in liver & kidney &
more slowly in muscle, brain & bone. Steady
state levels are achieved in about 7 days.
• Elimination is predominately via tubules & is
influenced by sodium balance. Depletion of
sodium can precipitate lithium toxicity.
4/24/2013 JAYESH PATIDAR 52
DOSAGES
Lithium is available in the market in the form of the
following preparation:
– Lithium carbonate: 300mg tablet (eg. Licab);
400mg sustained release tablets (eg.
Lithosun-SR).
– Lithium citrate: 300mg/5ml liquid.
The usual range of dose
per day in acute mania is 900-2100mg given in
2-3 divided doses. The treatment is started after
serial lithium estimation is done after a loading
dose of 600mg or 900mg of lithium to determine
the pharmacokinetics.
4/24/2013 JAYESH PATIDAR 53
BLOOD LITHIUM LEVEL
• Therapeutic levels = 0.8-1.2 mEq/L
(for treatment of acute mania)
• Prophylactic levels = 0.6-1.2 mEq/L
(for prevention of relapse in bipolar
disorder)
• Toxic lithium levels>2.0 mEq/L
4/24/2013 JAYESH PATIDAR 54
SIDE EFFECTS
• Neurological: Tremors, motor hyperactivity,
muscular weakness cogwheel rigidity, seizures,
neurotoxicity (delirium, abnormal involuntary
movements, seizures, coma).
• Renal: Polydipsia, polyuria, tubular enlargement,
nephritic syndrome.
• Cardiovascular: T-wave depression.
• Gastrointestinal: Nausea, vomiting, diarrhea,
abdominal pain & metallic taste.
• Endocrine: Abnormal thyroid function, goiter &
weight gain.
•
4/24/2013 JAYESH PATIDAR 55
Count…
• Dermatological: Acneiform eruptions,
popular eruptions & exacerbation of
psoriasis.
• Side-effect during pregnancy &
lactation: Teratogenic possibility,
increase incidence of Ebstein‘s anomaly
(distortion & downward displacement of
tricuspid value in right ventricle) when
taken in first trimester. Secreted in milk
& can cause toxicity in infant.
4/24/2013 JAYESH PATIDAR 56
Count…
• Sign & symptoms of
lithium toxicity (serum
lithium level>2.0
mEq/L):
– Ataxia
– Coarse tremor (hand)
– Nausea & vomiting
– Impaired memory
– Impaired concentration
– Nephrotoxicity
– Muscle weakness
– Convulsions
– Muscle twitching
– Dysarthria
– Lethargy
– Confusion
– Coma
– Hyperreflexia
– Nystagmus
4/24/2013 JAYESH PATIDAR 57
MANAGEMENT OF LITHIUM TOXICITY:-
• Discontinue the drug immediately.
• For significant short-term ingestions, residual
gastric content should be removed by induction of
emesis, gastric lavage adsorption with activated
charcoal.
• If possible instruct the patient to ingest fluids.
• Assess serum lithium levels, serum electrolytes,
renal functions, ECG as soon as possible.
• Maintenance of fluid & electrolyte balance.
• In a patient with serious manifestations of lithium
toxicity, hemodialysis should be initiated.
4/24/2013 JAYESH PATIDAR 58
CONTRAINDICATION OF LITHIUM:-
• Cardiac, renal, thyroid or neurological
dysfunctions
• Presence of blood dyscrasias
• During first trimester of pregnancy &
lactation
• Severe dehydration
• Hypothyroidism
• History of seizures
4/24/2013 JAYESH PATIDAR 59
NURSE’S RESPONSIBILITY:-
• The pre—lithium work up: A complete
physical history, ECG, blood studies (TC, DC,
FBS, BUN, Creatinine, electrolytes) urine
examination (routine & microscopic) must be
carried out. It is important to assess renal
function as renal side-effects are common &
the drug can be dangerous in an individual
with compromised kidney function. Thyroid
functions should also be assesses, as the
drug is known to depress the thyroid gland.
4/24/2013 JAYESH PATIDAR 60
Count…
To achieve therapeutic effect & prevent lithium toxicity,
the following precaution should be taken:
• Lithium must be taken on a regular basis,
preferably at the same time daily (for example, a
client taking lithium on TID schedule, who forget
a dose should wait until the next scheduled time
to take lithium & not take twice the amount at one
time, because toxicity can occur).
• When lithium therapy is initiated, mild side-effects
such as fine hand tremors, increased thirst &
urination, nausea, anorexia etc may develop,
Most of them are transient & do not represent
lithium toxicity.
4/24/2013 JAYESH PATIDAR 61
Count…
• Serious side-effects of lithium that necessitate its
discontinuance include vomiting, extreme hand tremor,
sedation, muscle weakness & vertigo. The psychiatrist
should be notified immediately if any of these effects
occur.
• Since polyuria can lead to dehydration with risk of lithium
intoxication, patients should be advised to drink enough
water to compensate for the fluid loss.
• Various situations may require an adjustment in the
amount of lithium administered to a client, such as the
addition of the new medicine to the client drug regimen, a
new diet or an illness with fever or excessive sweating.
They must be advised to consume large quantities of
water with salts, to prevent lithium toxicity due to
decreased sodium levels.
4/24/2013 JAYESH PATIDAR 62
Count…
• Frequent serum lithium level evaluation is
important. Blood for determination of lithium
levels should be drawn in the morning
approximately 12-14 hours after the last dose
was taken.
• The patient should be told about the importance
of regular follow up. In every six months, blood
sample should be taken for estimation of
electrolytes, urea, creatinine, a full blood count
& thyroid function test.
4/24/2013 JAYESH PATIDAR 63
CARBAMAZEPINE
4/24/2013 JAYESH PATIDAR 64
DESCRIPTION
• It is available in the market under
different trade names like Tegretol,
Mazetol, Zeptol & Zen Retard.
4/24/2013 JAYESH PATIDAR 65
MECHANISM OF ACTION
• Its mood stabilizing mechanism is
not clearly established. Its
anticonvulsant action may
however be by decreasing
synaptic transmission in the CNS.
4/24/2013 JAYESH PATIDAR 66
INDICATIONS
• Seizures-complex partial seizures, GTCS,
seizures due to alcohol withdrawal.
• Psychiatric disorders- rapid cycling bipolar
disorder, acute depression, impulse control
disorder, aggression, psychosis with
epilepsy, schizoaffective disorders,
borderline personality disorder, cocaine
withdrawal syndrome.
• Paroxysmal pain syndromes- trigeminal
neuralgia & phantom limb pain.
4/24/2013 JAYESH PATIDAR 67
DOSAGE
• The average daily dose is 600-1800
mg orally, in divided doses. The
therapeutic blood levels are 6-12
µg/ml. toxic blood levels are attained at
more than µg/ml.
4/24/2013 JAYESH PATIDAR 68
SIDE EFFECTS
• Drowsiness, confusion, headache,
ataxia, hypertension, arrhythmias, skin
rashes, steven-Johnson syndrome,
nausea, vomiting, diarrhea, dry mouth,
abdominal pain, jaundice, hepatitis,
oliguria, leucopenia, thrombocytopenia,
bone marrow depression leading to
aplastic anemia.
4/24/2013 JAYESH PATIDAR 69
NURSE’S RESPONCIBILITY
• Since the drug may cause dizziness &
drowsiness advise him to avoid driving &
other activities requiring alertness?
• Advise patient not to consume alcohol
when he is on the drug.
• Emphasize the importance of regular
follow-up visits & periodic examination of
blood count & monitoring of cardiac,
renal, hepatic & bone marrow functions.
4/24/2013 JAYESH PATIDAR 70
SODIUM
VALPROATE
(ENCORATE CHRONO,
VALPARIN, EPILEX,
EPIVAL)
4/24/2013 JAYESH PATIDAR 71
MECHANISM OF ACTION
• The drugs acts on gamma-
aminobutyric acid (GABA) an
inhibitory amino acid
neurotransmitters. GABA
receptors activation serves to
reduce neuronal excitability.
4/24/2013 JAYESH PATIDAR 72
INDICATION
• Acute mania, prophylactic treatment of
bipolar-I disorder, rapid cycling bipolar
disorder.
• Schizoaffective disorder.
• Seizures.
• Other disorders like bulimia nervosa,
obsessive-compulsive disorder, agitation
& PTSD.
4/24/2013 JAYESH PATIDAR 73
DOSAGE
• The usual dose is 15
mg/kg/day with a maximum of
60mg/kg/day orally.
4/24/2013 JAYESH PATIDAR 74
SIDE EFFECTS
• Nausea, vomiting, diarrhea,
sedation, ataxia, dysarthria,
tremor, weight gain, loss of hair,
thrombocytopenia, platelet
dysfunction.
4/24/2013 JAYESH PATIDAR 75
NURSE’S RESPONSIBILITY
• Explain to the patient to take the drug
immediately after food to reduce GI
irritation.
• Advise to come for regular follow-up &
periodic examination of blood count,
hepatic function & thyroid function.
Therapeutic serum level of valproic
acid is 50-100 micrograms/ml.
4/24/2013 JAYESH PATIDAR 76
ANTIANXIETY
AGENTS,
INCLUDING
SEDATIVES AND
HYPNOTICS
4/24/2013 JAYESH PATIDAR 77
DESCRIPTION
• Anxiety is a state which occurs in all
human being at sometime or the other.
• It is also a cardinal symptoms of many
psychiatric conditions.
• The drugs used to relieve anxiety are
called ANTIANXIETY OR ANXIOLYTIC
AGENTS. Antianxiety drugs relieve
moderate-to-severe anxiety & tension.
4/24/2013 JAYESH PATIDAR 78
MODE OF ACTION
• These non-barbiturate benzodiazepines
act as CNS depressants.
• It is believed that these drugs increase
or help the inhibitory neurotransmitter
action of gama-aminobutyric inhibitor in
all areas of CNS. So, there is inhibition
or control on the cortical & limbic system
of the brain, which is responsible for
emotions such as rage & anxiety.
4/24/2013 JAYESH PATIDAR 79
INDICATIONS
• Antianxiety agents are used to relieve mild, moderate &
severe anxiety associated with: emotional disorders
physical disorders excessive environmental stress
neuroses & mild depressive states without causing
excessive sedation or drowsiness.
• For control of alcohol withdrawal symptoms.
• To control convulsions.
• To produce skeletal muscle relaxation.
• To provide short-term sleep preoperatively, prior to
diagnosis & insomnia.
• Antianxiety agents should always be used in time-limited
regimen.
4/24/2013 JAYESH PATIDAR 80
CONTRAINDICATIONS
• Patients with renal or liver &
respiratory impairment are
given antianxiety drugs with
caution.
4/24/2013 JAYESH PATIDAR 81
CLASSIFICATION OF ANTIANXIETY
AGENTS:-
CHEMICAL GROUP &
GENERIC NAME
TRADE NAME RANGE OF DAILY
DOSAGE IN mgm
ACTION
I. Non-Barbiturates
A. Benzodiazepines
Chlordiazepoxide
Diazepam
Oxazepam
Prazepam
Chlorazapate
Flurazepam
Nitrazepam
lorazepam
Librium,
Equibrome
Valium,
Calmpose
Serepax
Verstran
Tranzene
Azene
Dalmane,
Nitravet
Mogadon
ativan
15-100
6-50
30-120
20-60
11.25-60
15-60
10-30
2-6
These are non-
barbiturate
benzodiazepines.
They produce a
tranquillizing
effect without
much sedation.
These drugs are
potential for
abuse.
4/24/2013 JAYESH PATIDAR 82
COUNT…
CHEMICAL GROUP &
GENERIC NAME
TRADE NAME RANGE OF DAILY
DOSAGE IN mgm
ACTION
A.Non-
Benzodiazepine
Propanediols
Meprobamate
Equanil
Miltown
Tybamate
1.2-1.6
1.2-1.6
1.2-1.6
These drugs
have sedative
action &
present a high
risk of abuse &
physical
dependence.
II. Antihistamines
Hydroxyzine
Atarax
vistaril
30-200
30-200
4/24/2013 JAYESH PATIDAR 83
CLASSIFICATION OF SEDATIVES AND
HYPNOTICS:-
CHEMICAL GROUP
& GENERIC NAME
TRDE NAME HYPNOTIC
DOSE RANGE-
DAILY IN mgm
SEDATIVE DOSE
DAILY IN mgm.
ACTION
III. Barbiturates
Amobarbidtal SA
Butabarbital SA
Pentobarbital LA
Phenobarbital LA
Thiopental USA
Amytal
Butisol
Nembutal
Luminal
pentothal
100-200
100-200
100-200
100-200
Used for
anasthesia
60-150
20-200
60-150
30-90
These drugs
cause drowsiness
lethargy,
decrased
alertness & sleep.
Tolerance to drug
can occur within
7-14 days,
resulting in
physical
dependence.
IV. Nonbarbiturates
4/24/2013 JAYESH PATIDAR 84
COUNT…
CHEMICAL GROUP &
GENERIC NAME
TRDE NAME HYPNOTIC
DOSE RANGE-
DAILY IN mgm
SEDATIVE DOSE
DAILY IN mgm.
ACTION
V. Quinazolines
Methaquualone Quaalude
Parest
Optimal
mandrax
150-300 250-300
VI. Acetylinic Alcohols
Ethchlorvynol placidyl
0.5gm-1gms 200-600mgm
VII. Chloral
Derivatives
Chloral hydrate
Chloral betaine
Noctaec
Beta-chlor
0.5gm-2gms
870mg-1gm
VIII. Monoureides
4/24/2013 JAYESH PATIDAR 85
SIDE – EFFECTS OF ANTIANXIETY,
SEDATIVES & HYPNOTICS
1)Central nervous system: drowsiness,
ataxia, confusion, depression, blurred
vision.
2)Cardiovascular system: hypotension,
palpitation, syncope.
3)Endocrine: change in libido.
4)Allergic: skin rash.
4/24/2013 JAYESH PATIDAR 86
COUNT…
5) Physical/psychological dependence non-
benzodiazepines & barbiturate group of
drugs has a high risk of abuse & physical
dependence.
6) Acute toxicity of barbiturate that can be
fetal when taken in excessive dosage
usually for suicide attempts. Overdose can
cause tachycardia, hypotension, shock,
respiratory depression, coma & death.
4/24/2013 JAYESH PATIDAR 87
NURSE’S RESPONSIBILITY
 Assessment of the patient, prior to the use of
antianxiety, sedative-hypnotic agents. If the patient
complains of sleep disturbance the causative factor
should be identified.
 Appropriate nursing measures to induce sleep
should be taken such as a calm & quite
environment, a cup of hot milk, good back care,
allowing the patient to read magazines, sitting with
the patient for some time for reassurance purpose.
 While administering the drug daily dose should be
given at bed time to promote a normal sleep
pattern, so that day-time activities are not affected.
4/24/2013 JAYESH PATIDAR 88
COUNT…
 Give IM injection deep into muscles to prevent
irritation.
 Look for side-effects, record & report immediately.
 If the patient complains of drowsiness tell him to
avoid using knife or any other dangerous equipment.
He should be instructed not to drive.
 Instruct the patient not to take any stimulant like
coffee, alcohol as they alter the effect of drugs.
 Avoid excessive use of these drugs to prevent the
onset of substance abuse or addiction.
 Drug should be reduced gradually, sudden stoppage of the
drug may cause REM (Rapid Eye Movements), insomnia,
dreams or nighmare, hyperexcitability, agitation or convulsions.
4/24/2013 JAYESH PATIDAR 89
ANTIPARKINSONIAN
AGENTS
4/24/2013 JAYESH PATIDAR 90
DESCRIPTION
• Antiparkinsonian agents are the specific
drugs to treat the extrapyramidal side-
effects of antipsychotic agents.
• Side-effects are parkinsonism,
akathisia, acute dystonia & tardive
dyskinesia.
• Anticholinergics, antihistamines &
amantidne are used to treat these side-
effects.
4/24/2013 JAYESH PATIDAR 91
MODE OF ACTION
• Anticholinergic drugs block the
secretion, thereby reducing the symptoms
of akathesia & acute dystonia. It is not
effective against tardive dyskinesia.
• Antihistamines have effects like
anticholinergic drugs. Amantadines are
dopamine-releasing agents from central
neurons. Studies show that this drug may
affect some clients with tardive
dyskinesia.
4/24/2013 JAYESH PATIDAR 92
INDICATION
• Antiparkinsonian drugs are
used to treat the
extrapyramidal symptoms.
4/24/2013 JAYESH PATIDAR 93
CONTRINDICATION
• Patient with history of closed angle glaucoma,
urinary or intestinal obstruction, hypersensitivity,
prostatic hypertrophy, tachycardia are not given
these drugs.
• The drugs are given with caution to patients with
mysthesia gravis, arthesclerosis & chronic
respiratory problems.
• Anticholinergic drugs: Amantadine is given with
caution to patients with renal impairment as
most of the medication is excreted through the
kidney.
4/24/2013 JAYESH PATIDAR 94
CLASSIFICATION
CHEMICAL & GENERIC
NAME
TRADE NAME DOSE RANGE PER
DAY mgm/Day
FROM OF
AVAILABILITY
I. Anticholinergic
Benztropine
Biperiden HCL
Hydrochiride
Trihexyphenidyl
Hydrochiride
Procyclidine
hydrochiride
Cogentin
Akinetone
Dyskinon
Pacitane
Parbenz
kemadrin
0.5-6.0
2.0-8.0
2.0-12.0
5.0-20mg
Tab, injection
-do-
-do-
Tab.
Tab.
II. Antihistamine
Diphenhydramine Benadryl 75-100
Capsule & syrup
III. Dopamine Drugs
L. Dopa
Amantadine Hydrochiride
Selegline
Carbidopa & L.Dopa.
Larodopa
Symmetrel
Deprenyl
Sinemet
2 gms-3gms
100-200gms
5-10mg
10-100mg
Tab.
Tab .
Tab.
Tab.
4/24/2013 JAYESH PATIDAR 95
SIDE-EFFECTS
• Anticholinergic:- Side-effects are dry mouth,
flushed, dry skin, blurred vision, photophobia,
increased heart rate, constipation, urinary
retention, mental confusion & excitement.
• Antihistamines:- Side-effects are drowsiness,
dizziness, anorexia, nausea, vomiting, euphoria,
orthostatic hypotension, weight gain, weakness &
tingling of hands.
• Amantadine:- Side-effects are mood changes,
slurred speech, insomnia, inability to concentrate,
dry mouth, livedo reticularis that is a red-blue
netlike discolouration of the skin which becomes
worse in winter.
4/24/2013 JAYESH PATIDAR 96
NURSE’S RESPONSIBILITY
 Observation- observation of the patient for side-
effects of anti-parkinsonian drugs such as
tachycardia, palpitation, sedation, drowsiness &
blurred vision.
 Maintain an intake output chart in case the patient
has urinary retention or constipation.
 Encourage adequate intake of fluids & roughage in
the diet.
 Record vital sign such as B.P., pulse & respiration
every four hours.
 Advise the patient not to get up quickly from a lying-
down position to sitting because of orthostatic
hypotension.4/24/2013 JAYESH PATIDAR 97
COUNT…
Educate the patient not to use hazardous
machinery or driving when he is on
anticholinergic drugs.
Encourage the patient to get his routine
eye check-up done for early detection of
blurred vision or glaucoma.
Record the medicine & side-effects
accurately.
Report & record any side-effects
observed to the physician.
4/24/2013 JAYESH PATIDAR 98
DRUGS USED IN
CHILD
PSYCHIATRY
4/24/2013 JAYESH PATIDAR 99
1. CLONIDINE
2. METHYLPHENIDATE (RITALIN):-
4/24/2013 JAYESH PATIDAR 100
CLONIDINE
4/24/2013 JAYESH PATIDAR 101
MECHANISM OF ACTION
• Alpha2- adrenergic receptors agonist.
• The agonist effects of clonidine on
presynaptic alpha 2-adrenergic
receptors result in a decrease in the
amount of neurotransmitters released
from the presynaptic nerve terminals.
This decrease serves generally to reset
the sympathetic tone at a lower level &
to decrease arousal.
4/24/2013 JAYESH PATIDAR 102
INDICATION
• Control of withdrawal symptoms from
opioids.
• Tourette‘s disorder
• Control of aggressive or hyperactive
behavior in children
• Autism.
4/24/2013 JAYESH PATIDAR 103
DOSAGE
• Usual starting dosage is 0.1mg
orally twice a day; the dosage can
be raised by 0.3 mg a day to an
appropriate level.
4/24/2013 JAYESH PATIDAR 104
SIDE-EFFECTS
• Dry mouth, dryness of eyes,
fatigue, irritability, sedation,
dizziness, nausea, vomiting,
hypotension & constipation.
4/24/2013 JAYESH PATIDAR 105
NURSE’S RESPONSIBILITY
• Monitor BP, the drug should be
withheld if the patient becomes
hypotensive.
• Advise frequent mouth rinses &
good oral hygiene for dry mouth.
4/24/2013 JAYESH PATIDAR 106
METHYLPHENIDATE
(RITALIN)
4/24/2013 JAYESH PATIDAR 107
DESCRIPTION
• Methylphenidate ,
dextroamphetamine &
pemoline are
sympathominetics.
4/24/2013 JAYESH PATIDAR 108
MECHANISM OF ACTION
• Sympathomimetics cause the stimulation of
alpha & beta-adrenergic receptors directly as
agonists & indirectly by stimulating the release
of dopamine & norepinephrine from
presynaptic terminals.
• Dextroamphetamine & methylphenidate are
also inhibitors of catecholamine reuptake,
especially dopamine reuptake & inhibitors of
monoamino oxidase.
• The net result of these activities is believed to
be the stimulation of the several brain regions.
4/24/2013 JAYESH PATIDAR 109
INDICATION
• Attention-deficit hyperactivity disorder
• Narcolepsy
• Depressive disorders
• Obesity
4/24/2013 JAYESH PATIDAR 110
DOSAGE
• Starting dose is 5-10 mg per
day orally, maximum daily
dose is 80mg/day.
4/24/2013 JAYESH PATIDAR 111
SIDE-EFFECTS
• Anorexia or dyspepsia, weight
loss, slowed growth, dizziness,
insomnia or nightmares,
dysphoric mood, tics &
psychosis.
4/24/2013 JAYESH PATIDAR 112
NURSE’S RESPONSIBILITY
• Assess mental status for chang in mood, level of
activity, degree of stimulation & aggressiveness.
• Ensure that the patient is protected from injury.
• Keep stimuli low & environment as quiet as
possible to discourage over stimulation.
• To decrease anorexia, the medication may be
administered immediately after meals. The
patient should be weighed regularly during
hospitalization & at home while on therapy with
CNS stimulants, due to the potential for anorexia/
weight loss & temporary interruptions of growth &
development.
4/24/2013 JAYESH PATIDAR 113
COUNT…
• To prevent insomnia administer last dose at
least 6 hours before bedtime.
• In children with behavioral disorders a drug
‗holiday‘ should be attempted periodically
under the direction of the physician to
determine effectiveness of the medication &
the need for continuation.
• Ensure that parents are aware of the delayed
effects of Ritalin. Therapeutic response may
not seen for 2-4 weeks; the drug should not be
discontinued for lack of immediate results.
4/24/2013 JAYESH PATIDAR 114
COUNT…
• Inform parents that OTC (over-the-counter)
medications should be avoided while the child
is on stimulant medication. Some OTC
medications, particularly cold & hay fever
preparation contain certain sympathomimetic
agents that could compound the effects of the
stimulants & create drug interactions that may
be toxic to the child.
• Ensure that parents are aware that the drug
should not be withdraw abruptly. Withdrawal
should be gradual & under the direction of the
physician.
4/24/2013 JAYESH PATIDAR 115
4/24/2013 JAYESH PATIDAR 116

Más contenido relacionado

La actualidad más candente

Ocd spectrum disorder
Ocd spectrum disorderOcd spectrum disorder
Ocd spectrum disorderHarsh shaH
 
Standards, challenges and scope of psychiatric nursing
Standards, challenges and scope of psychiatric nursingStandards, challenges and scope of psychiatric nursing
Standards, challenges and scope of psychiatric nursingjasleenbrar03
 
Extrapyramidal symptoms
Extrapyramidal symptomsExtrapyramidal symptoms
Extrapyramidal symptomsAziz Mohammad
 
Pharmacogenetics of-response-to-antidepressant-drugs
Pharmacogenetics of-response-to-antidepressant-drugsPharmacogenetics of-response-to-antidepressant-drugs
Pharmacogenetics of-response-to-antidepressant-drugsZoran M Pavlovic M.D.
 
Thought & its disorders (Dr. Subrata Naskar)
Thought & its disorders (Dr. Subrata Naskar)Thought & its disorders (Dr. Subrata Naskar)
Thought & its disorders (Dr. Subrata Naskar)Subrata Naskar
 
Drug use in elderly and techniques to avoid polypharmacy
Drug use in elderly and techniques to avoid polypharmacyDrug use in elderly and techniques to avoid polypharmacy
Drug use in elderly and techniques to avoid polypharmacyDrSahilKumar
 
Drugs safety in pregnancy
Drugs safety in pregnancyDrugs safety in pregnancy
Drugs safety in pregnancyDuraid Khalid
 
Opoid poisoning
Opoid poisoningOpoid poisoning
Opoid poisoninglamrin33
 
Pharm d research project
Pharm d research projectPharm d research project
Pharm d research projectSai Kumar
 
Investigation in psychiatry
Investigation in psychiatryInvestigation in psychiatry
Investigation in psychiatryNursing Path
 
Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophreniaSwati Arora
 
DRUGS IN PREGNANCY
 				DRUGS IN PREGNANCY 				DRUGS IN PREGNANCY
DRUGS IN PREGNANCYgolden4host
 
Obsessive Compulsive Disorder
Obsessive Compulsive DisorderObsessive Compulsive Disorder
Obsessive Compulsive Disordermeggooding
 

La actualidad más candente (20)

Lurasidone ppt
Lurasidone pptLurasidone ppt
Lurasidone ppt
 
Ocd spectrum disorder
Ocd spectrum disorderOcd spectrum disorder
Ocd spectrum disorder
 
Risperidone
RisperidoneRisperidone
Risperidone
 
Hydroxyzine 2020
Hydroxyzine 2020Hydroxyzine 2020
Hydroxyzine 2020
 
Standards, challenges and scope of psychiatric nursing
Standards, challenges and scope of psychiatric nursingStandards, challenges and scope of psychiatric nursing
Standards, challenges and scope of psychiatric nursing
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Behaviour therapy
Behaviour therapyBehaviour therapy
Behaviour therapy
 
Extrapyramidal symptoms
Extrapyramidal symptomsExtrapyramidal symptoms
Extrapyramidal symptoms
 
Antipsychotic drugs ppt
Antipsychotic drugs pptAntipsychotic drugs ppt
Antipsychotic drugs ppt
 
Pharmacogenetics of-response-to-antidepressant-drugs
Pharmacogenetics of-response-to-antidepressant-drugsPharmacogenetics of-response-to-antidepressant-drugs
Pharmacogenetics of-response-to-antidepressant-drugs
 
Thought & its disorders (Dr. Subrata Naskar)
Thought & its disorders (Dr. Subrata Naskar)Thought & its disorders (Dr. Subrata Naskar)
Thought & its disorders (Dr. Subrata Naskar)
 
Drug use in elderly and techniques to avoid polypharmacy
Drug use in elderly and techniques to avoid polypharmacyDrug use in elderly and techniques to avoid polypharmacy
Drug use in elderly and techniques to avoid polypharmacy
 
Psychosis
PsychosisPsychosis
Psychosis
 
Drugs safety in pregnancy
Drugs safety in pregnancyDrugs safety in pregnancy
Drugs safety in pregnancy
 
Opoid poisoning
Opoid poisoningOpoid poisoning
Opoid poisoning
 
Pharm d research project
Pharm d research projectPharm d research project
Pharm d research project
 
Investigation in psychiatry
Investigation in psychiatryInvestigation in psychiatry
Investigation in psychiatry
 
Management of schizophrenia
Management of schizophreniaManagement of schizophrenia
Management of schizophrenia
 
DRUGS IN PREGNANCY
 				DRUGS IN PREGNANCY 				DRUGS IN PREGNANCY
DRUGS IN PREGNANCY
 
Obsessive Compulsive Disorder
Obsessive Compulsive DisorderObsessive Compulsive Disorder
Obsessive Compulsive Disorder
 

Similar a Psychopharmacology

PSYCHOPHARMCOLOGY- INTRODUCTION.pdf
PSYCHOPHARMCOLOGY- INTRODUCTION.pdfPSYCHOPHARMCOLOGY- INTRODUCTION.pdf
PSYCHOPHARMCOLOGY- INTRODUCTION.pdfTejal Virola
 
Introduction to pharmacology 2018 updated
Introduction to pharmacology   2018 updated Introduction to pharmacology   2018 updated
Introduction to pharmacology 2018 updated Ahmed Ali
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacologydivya2709
 
Pocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorderPocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorderMike Wilhelm
 
Drug abuse
Drug abuseDrug abuse
Drug abuseShivaram
 
Psychotropic medications
Psychotropic medications Psychotropic medications
Psychotropic medications HI HI
 
Orientation to Pharmacology 2022.pptx
Orientation to Pharmacology 2022.pptxOrientation to Pharmacology 2022.pptx
Orientation to Pharmacology 2022.pptxJasperOmingo
 
Antidepressant medication advice for adults
Antidepressant medication   advice for adultsAntidepressant medication   advice for adults
Antidepressant medication advice for adultsMichel Newman
 
Psychiatric Medications
Psychiatric Medications Psychiatric Medications
Psychiatric Medications Mr. Psycho Sam
 
Drug addiction, tolerance and depandance
Drug addiction, tolerance and depandanceDrug addiction, tolerance and depandance
Drug addiction, tolerance and depandanceAMANKUMAR1483
 
df_treatmentapproaches_1_2016
df_treatmentapproaches_1_2016df_treatmentapproaches_1_2016
df_treatmentapproaches_1_2016zelko mustac
 
Facts about barbiturates
Facts about barbituratesFacts about barbiturates
Facts about barbituratesNikki Ting
 
Antipsychotic Drugs ppt.pptx
Antipsychotic Drugs ppt.pptxAntipsychotic Drugs ppt.pptx
Antipsychotic Drugs ppt.pptxParul Prasher
 

Similar a Psychopharmacology (20)

Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
PSYCHOPHARMACOLOGY
PSYCHOPHARMACOLOGYPSYCHOPHARMACOLOGY
PSYCHOPHARMACOLOGY
 
PSYCHOPHARMCOLOGY- INTRODUCTION.pdf
PSYCHOPHARMCOLOGY- INTRODUCTION.pdfPSYCHOPHARMCOLOGY- INTRODUCTION.pdf
PSYCHOPHARMCOLOGY- INTRODUCTION.pdf
 
Pharmacotherapy
PharmacotherapyPharmacotherapy
Pharmacotherapy
 
Drugs in Dementia.pdf
Drugs in Dementia.pdfDrugs in Dementia.pdf
Drugs in Dementia.pdf
 
GROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptxGROUP NO 6 PPT.pptx
GROUP NO 6 PPT.pptx
 
ANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptxANTIPSYCHOTICS.pptx
ANTIPSYCHOTICS.pptx
 
Introduction to pharmacology 2018 updated
Introduction to pharmacology   2018 updated Introduction to pharmacology   2018 updated
Introduction to pharmacology 2018 updated
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
Pocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorderPocket guide-medication-assisted-treatment-for-opioid-disorder
Pocket guide-medication-assisted-treatment-for-opioid-disorder
 
Drug abuse
Drug abuseDrug abuse
Drug abuse
 
Psychotropic medications
Psychotropic medications Psychotropic medications
Psychotropic medications
 
Orientation to Pharmacology 2022.pptx
Orientation to Pharmacology 2022.pptxOrientation to Pharmacology 2022.pptx
Orientation to Pharmacology 2022.pptx
 
Antidepressant medication advice for adults
Antidepressant medication   advice for adultsAntidepressant medication   advice for adults
Antidepressant medication advice for adults
 
Psychiatric Medications
Psychiatric Medications Psychiatric Medications
Psychiatric Medications
 
Drug addiction, tolerance and depandance
Drug addiction, tolerance and depandanceDrug addiction, tolerance and depandance
Drug addiction, tolerance and depandance
 
Psychopharmacology
PsychopharmacologyPsychopharmacology
Psychopharmacology
 
df_treatmentapproaches_1_2016
df_treatmentapproaches_1_2016df_treatmentapproaches_1_2016
df_treatmentapproaches_1_2016
 
Facts about barbiturates
Facts about barbituratesFacts about barbiturates
Facts about barbiturates
 
Antipsychotic Drugs ppt.pptx
Antipsychotic Drugs ppt.pptxAntipsychotic Drugs ppt.pptx
Antipsychotic Drugs ppt.pptx
 

Más de Nursing Path

Psychosocial care of coronavirus disease 2019
Psychosocial care of coronavirus disease 2019Psychosocial care of coronavirus disease 2019
Psychosocial care of coronavirus disease 2019Nursing Path
 
Isolation facility for covid-19
Isolation facility for covid-19Isolation facility for covid-19
Isolation facility for covid-19Nursing Path
 
Guidelines on clinical management of covid 19
Guidelines on clinical management of covid   19Guidelines on clinical management of covid   19
Guidelines on clinical management of covid 19Nursing Path
 
Fluid and electrolyte balance
Fluid and electrolyte balanceFluid and electrolyte balance
Fluid and electrolyte balanceNursing Path
 
Hospital Infection Control Programme
Hospital Infection Control ProgrammeHospital Infection Control Programme
Hospital Infection Control ProgrammeNursing Path
 
Outcome based education
Outcome based educationOutcome based education
Outcome based educationNursing Path
 
Selection and organization of learning experience
Selection and organization of learning experienceSelection and organization of learning experience
Selection and organization of learning experienceNursing Path
 
Universal Health Coverage
Universal Health CoverageUniversal Health Coverage
Universal Health CoverageNursing Path
 
Cardiopulmonary resuscitation
Cardiopulmonary resuscitationCardiopulmonary resuscitation
Cardiopulmonary resuscitationNursing Path
 
Fundamental of nursing practice exam 4
Fundamental of nursing practice exam 4Fundamental of nursing practice exam 4
Fundamental of nursing practice exam 4Nursing Path
 
Fundamentals of nursing practice exa1
Fundamentals of nursing practice exa1Fundamentals of nursing practice exa1
Fundamentals of nursing practice exa1Nursing Path
 
Fundamentals of nursing practice exam
Fundamentals of nursing practice examFundamentals of nursing practice exam
Fundamentals of nursing practice examNursing Path
 
Fundamentals of nursing practice exam
Fundamentals of nursing practice examFundamentals of nursing practice exam
Fundamentals of nursing practice examNursing Path
 
The enterobacteriaceae basic properties.ppsx x
The enterobacteriaceae basic properties.ppsx xThe enterobacteriaceae basic properties.ppsx x
The enterobacteriaceae basic properties.ppsx xNursing Path
 

Más de Nursing Path (20)

Psychosocial care of coronavirus disease 2019
Psychosocial care of coronavirus disease 2019Psychosocial care of coronavirus disease 2019
Psychosocial care of coronavirus disease 2019
 
Isolation facility for covid-19
Isolation facility for covid-19Isolation facility for covid-19
Isolation facility for covid-19
 
Guidelines on clinical management of covid 19
Guidelines on clinical management of covid   19Guidelines on clinical management of covid   19
Guidelines on clinical management of covid 19
 
Fluid and electrolyte balance
Fluid and electrolyte balanceFluid and electrolyte balance
Fluid and electrolyte balance
 
Hospital Infection Control Programme
Hospital Infection Control ProgrammeHospital Infection Control Programme
Hospital Infection Control Programme
 
Outcome based education
Outcome based educationOutcome based education
Outcome based education
 
Assessment
AssessmentAssessment
Assessment
 
Anxiety disorders
Anxiety disordersAnxiety disorders
Anxiety disorders
 
Selection and organization of learning experience
Selection and organization of learning experienceSelection and organization of learning experience
Selection and organization of learning experience
 
Universal Health Coverage
Universal Health CoverageUniversal Health Coverage
Universal Health Coverage
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Swine flu
Swine fluSwine flu
Swine flu
 
Cardiopulmonary resuscitation
Cardiopulmonary resuscitationCardiopulmonary resuscitation
Cardiopulmonary resuscitation
 
Abortion
AbortionAbortion
Abortion
 
Microbiology
MicrobiologyMicrobiology
Microbiology
 
Fundamental of nursing practice exam 4
Fundamental of nursing practice exam 4Fundamental of nursing practice exam 4
Fundamental of nursing practice exam 4
 
Fundamentals of nursing practice exa1
Fundamentals of nursing practice exa1Fundamentals of nursing practice exa1
Fundamentals of nursing practice exa1
 
Fundamentals of nursing practice exam
Fundamentals of nursing practice examFundamentals of nursing practice exam
Fundamentals of nursing practice exam
 
Fundamentals of nursing practice exam
Fundamentals of nursing practice examFundamentals of nursing practice exam
Fundamentals of nursing practice exam
 
The enterobacteriaceae basic properties.ppsx x
The enterobacteriaceae basic properties.ppsx xThe enterobacteriaceae basic properties.ppsx x
The enterobacteriaceae basic properties.ppsx x
 

Último

Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleCeline George
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Developmentchesterberbo7
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmStan Meyer
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptxmary850239
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...Nguyen Thanh Tu Collection
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQuiz Club NITW
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 

Último (20)

Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP Module
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Development
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and Film
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 

Psychopharmacology

  • 2. INTRODUCTION… • Psychopharmacology is the study of drugs used to treat psychiatric disorders. • Medications that affect psychic function, behavior or experience are called psychotropic medications. • They have significant effect on higher mental functions. • Psychopharmacological agents are first line treatment for almost all psychiatric ailments now a days. 4/24/2013 2JAYESH PATIDAR
  • 3. Count… • With the growing availability of a wide range of drugs to treat mental illness, the nurse practicing in modern psychiatric settings needs to have a sound knowledge of the pharmacokinetics involved, the benefits & potential risks of pharmacotherapy, as well as her own role & responsibility. 4/24/2013 3JAYESH PATIDAR
  • 4. DEFINITION OF PSYCHOTROPIC DRUGS Psychotropic drug is any drug that has primary effects on behavior, experience, or other psychological functions (Logman Dictionary of Psychology & Psychiatry). Psychotropic or psychoactive drugs can also be defined as chemical that affects the brain & nervous system, alter feelings & emotions. These drugs also affect the consciousness in various ways. A broad range of these drugs is used in emotional & mental illnesses. 4/24/2013 4JAYESH PATIDAR
  • 5. GENERAL GUIDELINES REGARDING DRUG ADMINISTRATION IN PSYCHIATRY • The nurse should not administer any drug unless there is a written order. Do not hesitate to consult the doctor when in doubt any medication. • All medications given must be charted on the patient‘s case record sheet. • In giving medication: – Always address the patient by name & make certain of his identification. – Do not leave the patient until the drug is swallowed. – Do not permit the patient to go to the bathroom to take medication. – Do not allow one patient to carry medicine to another. 4/24/2013 5 JAYESHPATIDAR
  • 6. Count… • If it is necessary to leave the patient to get water, do not leave the tray within the reach of the patient. • Do not force oral medication because of the danger of aspiration. This is especially important in stuporous patients. • Check drugs daily for any change in color, odor & number. • Bottle should be tightly closed & labeled. Labels should be written legibly & in bold lettering. Poison drugs are to be legibly labeled & to be kept in separate cupboard. 4/24/2013 6JAYESH PATIDAR
  • 7. Count… • Make sure that an adequate supply of drugs is on hand, but do not overstock. • Make sure no patient has access to the drug cupboard. • Drug cupboard should always be kept locked when not in use. Never allow a patient or worker to clean the drug cupboard. The drug cupboard keys should not be given to patients. 4/24/2013 7JAYESH PATIDAR
  • 8. PATIENT EDUCATION RELATED TO PSYCHOPHARMACOLOGY… • Nurses assess for drug side effects, evaluate desired effects, & make decisions about prn (pro re neta) medication. • Nurses must understand general principles of psychopharmacology & have specific knowledge related to psychotropic drugs. • Teaching patients can decrease the incidence of side effects while increasing compliance with the drug regimen. 4/24/2013 8JAYESH PATIDAR
  • 9. Specific areas of education include the following… 1. Discussion of side effects: Side effects can directly affect the patient‘s willingness to adhere to the drug regimen. The nurse should always inquire about the patient‘s response to a drug, both therapeutic responses & adverse responses 2. Drug interactions: Patients & families must be taught to discuss the effects of the addition of over-the-counter drugs, alcohol & illegal drugs to currently prescribed drugs. 4/24/2013 9JAYESH PATIDAR
  • 10. Count… 3. Discussion of safety issues: Because some drugs, such as tricyclic antidepressants, have a narrow therapeutic index, thoughts of self harm must be discussed. • Discuss on abruptly discontinued effects. • Many psychotropic drugs cause sedation or drowsiness, discussions concerning use of hazardous machinery, driving must be reviewed 4. Instructions for older adult patients: Because older individuals have a different pharmacokinetic profile than younger adults, special instructions concerning side effects & drug-drug interactions should be explained. 4/24/2013 10 JAYESH PATIDAR
  • 11. Count… 5. Instructions for pregnant or breastfeeding patient: As pregnant or breastfeeding patients have special risks associated with psychotropic drug therapy, special instructions should be tailored for these individuals. Teaching patients about their medications enables them to be mature participants in their own care & decreases undesirable side effects 4/24/2013 11JAYESH PATIDAR
  • 12. CLASSIFICATIONS OF PSYCHOTROPIC DRUGS 1. Antipsychotic agents 2. Antidepressant agents 3. Mood stabilizing drug 4. Anxiolytics & hypnosedatives 5. Antiepileptic drug 6. Antiparkinsonian drugs 7. Miscellaneous drugs which include stimulants, drugs used in eating disorders, drugs used in deaddiction, drugs uses in child psychiatry, vitamins, calcium channel blockers etc. 4/24/2013 12JAYESH PATIDAR
  • 14. DESCRIPTION:- • Antipsychotic agents are also known as neuroleptic, major tranquillizers, or phenothaiazines. • This group of drugs has a major clinical use in the treatment of psychosis. • Psychosis is a state in which a person‘s ability to recognize reality to communicate & to relate to others is severely impaired. 4/24/2013 14JAYESH PATIDAR
  • 15. MODE OF ACTION:- • Antipsychotic agents are thought to block the dopamine receptors. • Dopamine is a chemical which is released in the brain & causes psychotic thinking. • Increased production of dopamine transmits the nerve impulses to the brainstem faster than normal. This result in strange thoughts , hallucination & bizarre behavior. • Antipsychotics helps in blocking or reducing the activity of dopamine. • Antiemetic is another property of antipsychotic agents. They are also used in hiccoughs. 4/24/2013 15JAYESH PATIDAR
  • 16. Class Examples of drugs Trade name Oral dose mg/day Parenteral dose (mg) Phenothiazines Chlorpromazine Triflupromazine Thioridazine Trifluoperazine Fluphenazine decanoate Megatil Largactil Tranchlor Siquil Thioril, Melleril Ridazin Espazine prolinate 300-1500 100-400 300-800 15-60 - 50-100 IM only 30-60 IM only 1-5 IM 25-50 IM every 1-3 weeks. Thioxanthenes flupenthixol fluanxol 3-40 CLASSIFICATION:- 4/24/2013 16JAYESH PATIDAR
  • 17. Class Examples of drugs Trade name Oral dose mg/day Parenteral dose (mg) Diphenylbutyl Pimozide orap 4-20 piperidines penfluridol flumap 20-60 weekly - Indolic derivatives molindone mobam 50-225 - Dibenzoxazepines loxapine loxapac 25-100 - Atypical antipsychotics Clozapine Risperidone Olanzapine Quetiapine Ziprasidone Sizopine, Lozapin Sizodon, sizomax Oleanz Qutan Zisper 50-450 2-10 10-20 150-750 mg 20-80 mg Others reserpine serpasil 0.5-50 Count… 4/24/2013 17JAYESH PATIDAR
  • 18. INDICATIONS  Organic psychiatric disorders: • Delirium • Dementia • Delirium tremens • Drug-induced psychosis & other organic mental disorders  Functional disorders: • Schizophrenia • Schizoaffective disorders • Paranoid disorders  Mood disorders: • Mania • Major depression with psychotic symptoms  Childhood disorders: • Attention-deficit hyperactivity disorder • Autism • Enuresis • Conduct disorder 4/24/2013 JAYESH PATIDAR 18
  • 19. Count…  Neurotic & other psychiatric disorders: • Anorexia nervosa • Intractable obsessive- compulsive disorder • Severe, intractable & disabling anxiety  Medical disorders: • Huntington‘s chorea • Intractable hiccough • Nausea & vomiting • Tic disorder • Eclampsia • Heart stroke severe pain in malignancy tetanus 4/24/2013 JAYESH PATIDAR 19
  • 20. PHARMACOKINETICS • Antipsychotics when administered orally are absorbed variably from the gastrointestinal tract, with uneven blood levels. • They are highly bound to plasma as well as tissue proteins. Brain concentration is higher than the plasma concentration. • They are metabolized in the liver, & excreted mainly through the kidneys. The elimination half-life varies from 10 to 24 hours. • Most of the antipsychotics tend to have a therapeutic window. If the blood level is below this window, the drug is ineffective. If the blood level is higher than the upper limit of the window, there is toxicity or the drug is again ineffective. 4/24/2013 JAYESH PATIDAR 20
  • 21. SIDE-EFFECTS 1) Extrapyramidal symptoms (EPS) i. Neuroleptic-induced parkinsonism:- occur in 40% of the patients presenting extrapyramidal symptoms. There are two varieties of parkinsonia symptoms: a. Akinetic Form:- Appears in the first week of administration of antipsychotic drugs. The characteristics of akinetic form are: Difficulty in masticating movements, weakness & muscle fatigue. 4/24/2013 JAYESH PATIDAR 21
  • 22. Count… b. Agitating Form of parkinsonian Symptoms include:- Tremors at rest, rigidity & mask-like face. Most characteristic features of parkinsonism are:- Rigidity of muscles Motor retardation salivation slurred speech mask-like face shuffling gait Anticholinergi drugs are given as treatments. 4/24/2013 JAYESH PATIDAR 22
  • 23. Count… ii. Akathisia:- Akathisia occurs in 50% of all the patients presenting extrapyrimidal symptoms. The common characteristics: Restless ―walking in place‖. Difficulty in sitting still, or strong urge to move about- referred to as ―Walkies & Talkies‖ by haris . generally occurs after two weeks of treatment. Before administering anti-parkinsonian medication anxiety should be ruled out. 4/24/2013 JAYESH PATIDAR 23
  • 24. Count… iii. Dystonia:- Dystonia occurs in 6% of total number of patient‘s presenting EPS. The characteristic features are: rapidly developing contraction of muscles of the tongue, jaw, neck (producing torticollis) & etraocular muscles. Combined torticolis & extraocular spasm results in an oculogyric crisis in which eyes looked upward, head is turned to one side. Dystonia is painful & gives a frightening experience to the patient. Constant observation of the patient should be made. Dystonia occurs within a few minutes of giving medicine or after several hours. 4/24/2013 JAYESH PATIDAR 24
  • 25. Count… iv. Tardive Dyskinesia:- This occur due to abrupt termination or reduction of the antipsychotic drug after long-term-high-dose therapy. Tardive dyskinesia is characterized by involuntary rhythmic, stereotyped movements, protrusion of the tongue, puffing of cheeks, chewing movements, involuntary movements of extremities & trunk. These symptoms occur in 3% of patients. Antipsychotics should be stoped immediately. There is no treatment, symptoms may appear for years. It is irreversible. 4/24/2013 JAYESH PATIDAR 25
  • 26. Count… V. Neuroleptic Malignant Syndrome (NMS):- This is a rare complication of antipsychotic agents & is usually fetal. Many develop within hours or after years of continued drug use. Symptoms include hyperpyrexia, severe muscle rigidity, altered consciousness, blood pressure changes, increased count of W.B.C. symptoms appear suddenly when medication is started & can persist for 10-14 days or longer. Symptomatic treatment is given to patients. 4/24/2013 JAYESH PATIDAR 26
  • 27. Count… 2) Autonomic Nervous System:- Dry mouth, blurred vision, constipation, urinary hesitance or retention & under rare circumstances paralytic ileus. 3) Cardio-Vascular:- Tachycardia, orthostatic hypotension & reversible arrhythmias. 4) Blood or Hematopoietic:- Agrunulocytosis (marked decrease in leukocytes system especially with chlorpramozine) leucopenia, leukocytosis. 4/24/2013 JAYESH PATIDAR 27
  • 28. Count… 5) Endocrine Disruptions:- Menstrual irregularities, including amenorrhea & false positive pregnancy tests, breast enlargement, lactation, weight gain, changes in libido, impotence, glycosuria, hyperglycemia. 6) Gastro-Intestinal:- Anorexia, constipation, diarrhea, hypersalivation, nausea, vomiting, obstructive jaundice. 7) Allergic effects:- Dermatitis, photosensitization, pigment deposits. 4/24/2013 JAYESH PATIDAR 28
  • 29. Count… 8) Occular Effcts:- Blurring of vision, pigmentation of cornea & lens & retinopathy. 9) Hepatic Side-effects:- Liver toxicity occurs in 0.5% of cases presenting EPS. It is a hypersensitivity reaction & dose dependent. Onset of symptoms is within the first one month of treatment. Symptoms may be fever, chills, nausea, malaise, prurites & jaundice. 4/24/2013 JAYESH PATIDAR 29
  • 30. NURSE’S RESPONCIBILITY  Close observation, especially when the antipsychotic are just started. The expected results are reduction in aggressive hyperactive behavior & disorganized thoughts. Look for the possible side-effects.  Extrapyramidal reaction, i.e. Parkinsonism, akinesia, akathisia, dystonia, & tardive dyskinesia. These symptoms are reduced/treated with early observation, reporting & use of anti-parkinsonion or anticholinergic medication.  Observe drowsiness. Medicine should be administered at bed time. Report if the drowsiness persists for a very long time. The patient should be advised not to drive & handle hazardous machinery while taking antipsychotic drugs. Observe for sore throat, fever due to agranulocytosis. 4/24/2013 JAYESH PATIDAR 30
  • 31. Count…  Record blood pressure of the patient on antipsychotic drugs. If the BP is drops by 20 to30 mm of hg in the patient, immediate reporting & intervention should be done. The patient should be made aware of the possibility of dizziness & injuries after receiving medication & injection due to orthostatic hypotension.  Accurate rout of medication- antipsychotic drugs are not given subcutaneously unless specially prescribed as they cause tissue irritation. These drugs should be given deep IM.  Dry mouth may be may be reduced by encouraging the patient to rinse his or her mouth frequently. Give a piece of lemon or chewing gum. Good oral hygiene should also be maintained. 4/24/2013 JAYESH PATIDAR 31
  • 32. Count…  Blurred or impaired vision in the patient causes anxiety & annonyance to him. The patient should be encouraged to inform these symptoms immediately. Blurred vision or brown coloured vision, night blindness can be permanent due to pigmentary retinopathy.  The patient on antipsychotic drugs may have weight gain. Weight record should be maintained. The patient may be encouraged on a low salt & planned caloric diet.  The patient may complain of gastric irritation. He should be discouraged to take antacid as there will be decreased absorption of antipsychotic drugs.  An intake output chart should be maintained specially for male patients who are confined to bed & have an enlarged prostate gland. Encourage at least 2500 ml of liquid intake. 4/24/2013 JAYESH PATIDAR 32
  • 33. Count…  The patient should be advised to protect his skin, by not going in the sun & to wear protective clothing & sunglasses.  The patient should be explained not to increase or decrease or stop taking drugs without discussing with his doctor. The drugs should be withdrawn slowly to avoid nausea or seizures.  The nurse should find out menstrual changes from the female patient. Sometimes the patient may complain of fever, upper abdominal pain, nausea, jaundice & diarrhea. These symptoms can be due to cholestatic jaundice. The nurse should stop the medicine immediately & inform the doctor.  Reassurance to relatives- The patient & his relatives should be explained that desired effects will be achieved after weeks of medication, so the relatives need to wait for the effects of the drugs. 4/24/2013 JAYESH PATIDAR 33
  • 35. DESCRIPTION • Antidepressant agents are used in affective disorders or disturbances mainly to treat depressive disorders caused by emotional or environmental stressors. • Several groups of affective disturbances are treatable by antidepressants. 4/24/2013 JAYESH PATIDAR 35
  • 36. MODE OF ACTION • Antidepressant drugs are classified as Tricyclics, Tetracyclics & MAO inhibitors. Research studies have shown reduced levels of norepinephrine (NE) & serotonin (5-HT) in the space between nerve ending carrying message from one nerve cell to another cause depression. • Tricyclic antidepressants & MAO inhibitors increase these neurotransmitters i.e. norepinephrine & sertinin to the synaptic receptors in the central nervous system. Tricyclic inhibitors block the reuptake of NE & 5-HT & MAO inhibitors block the action of MONOamine oxidize in breaking down excess of NE & 5-HT at the presynaptic neuron. 4/24/2013 JAYESH PATIDAR 36
  • 37. CLASSIFICATION CLASS EXAMPLES OF DRUGS TRADE NAME ORAL DOSE (mg/day) Tricyclic antidepressants (TCAs) Imipramine Amitriptyline Clomipramine Dothiepin mianserin Antidep Tryptomer Anafranil Prothiaden depnon 75-300 75-300 75-300 75-300 30-120 Selective serotonin reuptake inhibitors (SSRIs) Fluoxetine Sertraline Fludac Serenata 10-80 50-200 Dopaminergic antidepressants fluvoxamine faverin 50-300 Atypical antidepressants amineptine survector 100-400 Monoamine oxidase inhibitors (MAOIs) Trazodone isocarboxazid Trazalon Marplan 150-600 10-304/24/2013 JAYESH PATIDAR 37
  • 38. INDICATIONS  Depression • Depressive episode • Dysthymia • Reactive depression • Secondary depression • Abnormal grief reaction  Childhood psychiatric disorders • Enuresis • Separation anxiety disorder • Somnambulism • School phobia • Night terrors  Other psychiatric disorders • Panic attack • Generalized anxiety disorder • Agrophobia, social phobia • OCD with or without depression • Eating disorder • Borderline personality disorder • Post-traumatic stress disorder • Depersonalization syndrome  Medical disorder • Chronic pain • Migraine • Peptic ulcer disease 4/24/2013 JAYESH PATIDAR 38
  • 39. PHARMACOKINETICS • Antidepressants are highly lipophilic & protein-bound. The half-life is long & usually more than 24 hours. • It is predominantly metabolized in the liver. 4/24/2013 JAYESH PATIDAR 39
  • 40. CONTRAINDICATION • Antidepressants are given with caution to patients with cardiovascular disorder because they cause arrhythmias. • They increase symptoms of psychosis & mania in cases of manic-depressive psychosis. • Drugs are given with caution to prevents with liver disorders. 4/24/2013 JAYESH PATIDAR 40
  • 41. SIDE EFFECTS 1) Autonomic side-effects: Dry mouth, constipation, cycloplegia, mydriasis, urinary retention, orthostatic hypotension, impotence, impaired ejaculation, delirium & aggravation of glaucoma. 2) CNS effects:- Sedation, tremor & other extrapyramidal symptoms, withdrawal syndrome, seizures, jitteriness syndrome, precipitation of mania. 3) Cardiac side-effects:- Tachycardia, ECG changes, arrhythmias, direct myocardial depression, quinidine-like action(decreased conduction time). 4/24/2013 JAYESH PATIDAR 41
  • 42. Count… 4) Allergic side-effects:- Agranulocytosis, cholestatic jaundice, skin rashes, systemic vasculitis. 5) Metabolic & endocrine side-effects:- weight gain 6) Special effects of MAOI drugs:- Hypertensive crises, severe hepatic necrosis, hyperpyrexia. 4/24/2013 JAYESH PATIDAR 42
  • 43. NURSE’S RESPONSIBILITY  Observation of the side-effects & monitoring the changes noted are very significant to prevent complications due to antidepressant agents.  Encourage the patient to take medicine at bed time due to a sedative effect. Dryness of mouth to decrease.  Give plenty of fluids orally. Lemonade or chewing gum should be given. A few sips of water also help the patient.  Do not give medicine empty stomach as the patient complains of nausea & vomiting. 4/24/2013 JAYESH PATIDAR 43
  • 44. Count…  Accurate recording of intake & output of the patient should be maintained to check if he has retention of urine.  If the patient complains of dizziness or light headedness he/she should be encouraged to get up slowly & sit in the bed before standing. These symptoms may due to orthostatic hypotension. The patient should be reassured that these symptoms are for a short period only. Some patients may present hypertension.  Accurate recording of vital signs like B.P. & pulse.  The nurse should be able to interpret the blood reports specially blood sugar level & W.B.C. count. If the patient complains of sore throat, fever, malaise, it should be reported to the physician on duty. These symptoms may be due to agranulocytosis or hyperglycemia. 4/24/2013 JAYESH PATIDAR 44
  • 45. Count…  To relieve constipation plenty of fluids & roughage should be encouraged in the diet.  If the patient complains of sexual dysfunction inform the physician immediately & stop the drug.  If the patient is presenting symptoms of pressure of speech, increased motor activity & elated mood, the physician should be informed & the drug should be stopped immediately.  Antidepressant tricyclic drugs begin therapeutic effects within four to eight weeks.  Accurate recording of the observation made. 4/24/2013 JAYESH PATIDAR 45
  • 47. Mood stabilizers are used for the treatment of bipolar affective disorders. Some commonly used mood stabilizers are:- 1. Lithium 2. Carbamazepine 3. Sodium Valproate 4/24/2013 JAYESH PATIDAR 47
  • 49. DESCRIPTION • Lithium is an element with atomic number 3 & atomic weight 7. • It was discovered by FJ Cade in 1949, & is a most effective & commonly used drug in the treatment of mania. 4/24/2013 JAYESH PATIDAR 49
  • 50. MODE OF ACTION The probable mechanisms of action can be: • It accelerates presynaptic re-uptake & destruction of catecholamines, like norepinephrine. • It inhibits the release of catecholamines at the synapse. • It decreases postsynaptic serotonin receptor sensitivity. All these actions result in decreased catecholamine activity, thus ameliorating mania. 4/24/2013 JAYESH PATIDAR 50
  • 51. INDICATION  Acute mania  Prophylaxis for bipolar & unipolar mood disorder.  Schizoaffective disorder  Cyclothymia  Impulsivity & aggression Other disorders: – Premenstrual dysphoric disorder – Bulimia nervosa – Borderline personality disorder – Episodes of binge drinking – Trichotillomania – Cluster headaches 4/24/2013 JAYESH PATIDAR 51
  • 52. PHARMACOKINETICS • Lithium is readily absorbed with peak plasma levels occurring 2-4 hours after a single oral dose of lithium carbonate. • Lithium is distributed rapidly in liver & kidney & more slowly in muscle, brain & bone. Steady state levels are achieved in about 7 days. • Elimination is predominately via tubules & is influenced by sodium balance. Depletion of sodium can precipitate lithium toxicity. 4/24/2013 JAYESH PATIDAR 52
  • 53. DOSAGES Lithium is available in the market in the form of the following preparation: – Lithium carbonate: 300mg tablet (eg. Licab); 400mg sustained release tablets (eg. Lithosun-SR). – Lithium citrate: 300mg/5ml liquid. The usual range of dose per day in acute mania is 900-2100mg given in 2-3 divided doses. The treatment is started after serial lithium estimation is done after a loading dose of 600mg or 900mg of lithium to determine the pharmacokinetics. 4/24/2013 JAYESH PATIDAR 53
  • 54. BLOOD LITHIUM LEVEL • Therapeutic levels = 0.8-1.2 mEq/L (for treatment of acute mania) • Prophylactic levels = 0.6-1.2 mEq/L (for prevention of relapse in bipolar disorder) • Toxic lithium levels>2.0 mEq/L 4/24/2013 JAYESH PATIDAR 54
  • 55. SIDE EFFECTS • Neurological: Tremors, motor hyperactivity, muscular weakness cogwheel rigidity, seizures, neurotoxicity (delirium, abnormal involuntary movements, seizures, coma). • Renal: Polydipsia, polyuria, tubular enlargement, nephritic syndrome. • Cardiovascular: T-wave depression. • Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain & metallic taste. • Endocrine: Abnormal thyroid function, goiter & weight gain. • 4/24/2013 JAYESH PATIDAR 55
  • 56. Count… • Dermatological: Acneiform eruptions, popular eruptions & exacerbation of psoriasis. • Side-effect during pregnancy & lactation: Teratogenic possibility, increase incidence of Ebstein‘s anomaly (distortion & downward displacement of tricuspid value in right ventricle) when taken in first trimester. Secreted in milk & can cause toxicity in infant. 4/24/2013 JAYESH PATIDAR 56
  • 57. Count… • Sign & symptoms of lithium toxicity (serum lithium level>2.0 mEq/L): – Ataxia – Coarse tremor (hand) – Nausea & vomiting – Impaired memory – Impaired concentration – Nephrotoxicity – Muscle weakness – Convulsions – Muscle twitching – Dysarthria – Lethargy – Confusion – Coma – Hyperreflexia – Nystagmus 4/24/2013 JAYESH PATIDAR 57
  • 58. MANAGEMENT OF LITHIUM TOXICITY:- • Discontinue the drug immediately. • For significant short-term ingestions, residual gastric content should be removed by induction of emesis, gastric lavage adsorption with activated charcoal. • If possible instruct the patient to ingest fluids. • Assess serum lithium levels, serum electrolytes, renal functions, ECG as soon as possible. • Maintenance of fluid & electrolyte balance. • In a patient with serious manifestations of lithium toxicity, hemodialysis should be initiated. 4/24/2013 JAYESH PATIDAR 58
  • 59. CONTRAINDICATION OF LITHIUM:- • Cardiac, renal, thyroid or neurological dysfunctions • Presence of blood dyscrasias • During first trimester of pregnancy & lactation • Severe dehydration • Hypothyroidism • History of seizures 4/24/2013 JAYESH PATIDAR 59
  • 60. NURSE’S RESPONSIBILITY:- • The pre—lithium work up: A complete physical history, ECG, blood studies (TC, DC, FBS, BUN, Creatinine, electrolytes) urine examination (routine & microscopic) must be carried out. It is important to assess renal function as renal side-effects are common & the drug can be dangerous in an individual with compromised kidney function. Thyroid functions should also be assesses, as the drug is known to depress the thyroid gland. 4/24/2013 JAYESH PATIDAR 60
  • 61. Count… To achieve therapeutic effect & prevent lithium toxicity, the following precaution should be taken: • Lithium must be taken on a regular basis, preferably at the same time daily (for example, a client taking lithium on TID schedule, who forget a dose should wait until the next scheduled time to take lithium & not take twice the amount at one time, because toxicity can occur). • When lithium therapy is initiated, mild side-effects such as fine hand tremors, increased thirst & urination, nausea, anorexia etc may develop, Most of them are transient & do not represent lithium toxicity. 4/24/2013 JAYESH PATIDAR 61
  • 62. Count… • Serious side-effects of lithium that necessitate its discontinuance include vomiting, extreme hand tremor, sedation, muscle weakness & vertigo. The psychiatrist should be notified immediately if any of these effects occur. • Since polyuria can lead to dehydration with risk of lithium intoxication, patients should be advised to drink enough water to compensate for the fluid loss. • Various situations may require an adjustment in the amount of lithium administered to a client, such as the addition of the new medicine to the client drug regimen, a new diet or an illness with fever or excessive sweating. They must be advised to consume large quantities of water with salts, to prevent lithium toxicity due to decreased sodium levels. 4/24/2013 JAYESH PATIDAR 62
  • 63. Count… • Frequent serum lithium level evaluation is important. Blood for determination of lithium levels should be drawn in the morning approximately 12-14 hours after the last dose was taken. • The patient should be told about the importance of regular follow up. In every six months, blood sample should be taken for estimation of electrolytes, urea, creatinine, a full blood count & thyroid function test. 4/24/2013 JAYESH PATIDAR 63
  • 65. DESCRIPTION • It is available in the market under different trade names like Tegretol, Mazetol, Zeptol & Zen Retard. 4/24/2013 JAYESH PATIDAR 65
  • 66. MECHANISM OF ACTION • Its mood stabilizing mechanism is not clearly established. Its anticonvulsant action may however be by decreasing synaptic transmission in the CNS. 4/24/2013 JAYESH PATIDAR 66
  • 67. INDICATIONS • Seizures-complex partial seizures, GTCS, seizures due to alcohol withdrawal. • Psychiatric disorders- rapid cycling bipolar disorder, acute depression, impulse control disorder, aggression, psychosis with epilepsy, schizoaffective disorders, borderline personality disorder, cocaine withdrawal syndrome. • Paroxysmal pain syndromes- trigeminal neuralgia & phantom limb pain. 4/24/2013 JAYESH PATIDAR 67
  • 68. DOSAGE • The average daily dose is 600-1800 mg orally, in divided doses. The therapeutic blood levels are 6-12 µg/ml. toxic blood levels are attained at more than µg/ml. 4/24/2013 JAYESH PATIDAR 68
  • 69. SIDE EFFECTS • Drowsiness, confusion, headache, ataxia, hypertension, arrhythmias, skin rashes, steven-Johnson syndrome, nausea, vomiting, diarrhea, dry mouth, abdominal pain, jaundice, hepatitis, oliguria, leucopenia, thrombocytopenia, bone marrow depression leading to aplastic anemia. 4/24/2013 JAYESH PATIDAR 69
  • 70. NURSE’S RESPONCIBILITY • Since the drug may cause dizziness & drowsiness advise him to avoid driving & other activities requiring alertness? • Advise patient not to consume alcohol when he is on the drug. • Emphasize the importance of regular follow-up visits & periodic examination of blood count & monitoring of cardiac, renal, hepatic & bone marrow functions. 4/24/2013 JAYESH PATIDAR 70
  • 72. MECHANISM OF ACTION • The drugs acts on gamma- aminobutyric acid (GABA) an inhibitory amino acid neurotransmitters. GABA receptors activation serves to reduce neuronal excitability. 4/24/2013 JAYESH PATIDAR 72
  • 73. INDICATION • Acute mania, prophylactic treatment of bipolar-I disorder, rapid cycling bipolar disorder. • Schizoaffective disorder. • Seizures. • Other disorders like bulimia nervosa, obsessive-compulsive disorder, agitation & PTSD. 4/24/2013 JAYESH PATIDAR 73
  • 74. DOSAGE • The usual dose is 15 mg/kg/day with a maximum of 60mg/kg/day orally. 4/24/2013 JAYESH PATIDAR 74
  • 75. SIDE EFFECTS • Nausea, vomiting, diarrhea, sedation, ataxia, dysarthria, tremor, weight gain, loss of hair, thrombocytopenia, platelet dysfunction. 4/24/2013 JAYESH PATIDAR 75
  • 76. NURSE’S RESPONSIBILITY • Explain to the patient to take the drug immediately after food to reduce GI irritation. • Advise to come for regular follow-up & periodic examination of blood count, hepatic function & thyroid function. Therapeutic serum level of valproic acid is 50-100 micrograms/ml. 4/24/2013 JAYESH PATIDAR 76
  • 78. DESCRIPTION • Anxiety is a state which occurs in all human being at sometime or the other. • It is also a cardinal symptoms of many psychiatric conditions. • The drugs used to relieve anxiety are called ANTIANXIETY OR ANXIOLYTIC AGENTS. Antianxiety drugs relieve moderate-to-severe anxiety & tension. 4/24/2013 JAYESH PATIDAR 78
  • 79. MODE OF ACTION • These non-barbiturate benzodiazepines act as CNS depressants. • It is believed that these drugs increase or help the inhibitory neurotransmitter action of gama-aminobutyric inhibitor in all areas of CNS. So, there is inhibition or control on the cortical & limbic system of the brain, which is responsible for emotions such as rage & anxiety. 4/24/2013 JAYESH PATIDAR 79
  • 80. INDICATIONS • Antianxiety agents are used to relieve mild, moderate & severe anxiety associated with: emotional disorders physical disorders excessive environmental stress neuroses & mild depressive states without causing excessive sedation or drowsiness. • For control of alcohol withdrawal symptoms. • To control convulsions. • To produce skeletal muscle relaxation. • To provide short-term sleep preoperatively, prior to diagnosis & insomnia. • Antianxiety agents should always be used in time-limited regimen. 4/24/2013 JAYESH PATIDAR 80
  • 81. CONTRAINDICATIONS • Patients with renal or liver & respiratory impairment are given antianxiety drugs with caution. 4/24/2013 JAYESH PATIDAR 81
  • 82. CLASSIFICATION OF ANTIANXIETY AGENTS:- CHEMICAL GROUP & GENERIC NAME TRADE NAME RANGE OF DAILY DOSAGE IN mgm ACTION I. Non-Barbiturates A. Benzodiazepines Chlordiazepoxide Diazepam Oxazepam Prazepam Chlorazapate Flurazepam Nitrazepam lorazepam Librium, Equibrome Valium, Calmpose Serepax Verstran Tranzene Azene Dalmane, Nitravet Mogadon ativan 15-100 6-50 30-120 20-60 11.25-60 15-60 10-30 2-6 These are non- barbiturate benzodiazepines. They produce a tranquillizing effect without much sedation. These drugs are potential for abuse. 4/24/2013 JAYESH PATIDAR 82
  • 83. COUNT… CHEMICAL GROUP & GENERIC NAME TRADE NAME RANGE OF DAILY DOSAGE IN mgm ACTION A.Non- Benzodiazepine Propanediols Meprobamate Equanil Miltown Tybamate 1.2-1.6 1.2-1.6 1.2-1.6 These drugs have sedative action & present a high risk of abuse & physical dependence. II. Antihistamines Hydroxyzine Atarax vistaril 30-200 30-200 4/24/2013 JAYESH PATIDAR 83
  • 84. CLASSIFICATION OF SEDATIVES AND HYPNOTICS:- CHEMICAL GROUP & GENERIC NAME TRDE NAME HYPNOTIC DOSE RANGE- DAILY IN mgm SEDATIVE DOSE DAILY IN mgm. ACTION III. Barbiturates Amobarbidtal SA Butabarbital SA Pentobarbital LA Phenobarbital LA Thiopental USA Amytal Butisol Nembutal Luminal pentothal 100-200 100-200 100-200 100-200 Used for anasthesia 60-150 20-200 60-150 30-90 These drugs cause drowsiness lethargy, decrased alertness & sleep. Tolerance to drug can occur within 7-14 days, resulting in physical dependence. IV. Nonbarbiturates 4/24/2013 JAYESH PATIDAR 84
  • 85. COUNT… CHEMICAL GROUP & GENERIC NAME TRDE NAME HYPNOTIC DOSE RANGE- DAILY IN mgm SEDATIVE DOSE DAILY IN mgm. ACTION V. Quinazolines Methaquualone Quaalude Parest Optimal mandrax 150-300 250-300 VI. Acetylinic Alcohols Ethchlorvynol placidyl 0.5gm-1gms 200-600mgm VII. Chloral Derivatives Chloral hydrate Chloral betaine Noctaec Beta-chlor 0.5gm-2gms 870mg-1gm VIII. Monoureides 4/24/2013 JAYESH PATIDAR 85
  • 86. SIDE – EFFECTS OF ANTIANXIETY, SEDATIVES & HYPNOTICS 1)Central nervous system: drowsiness, ataxia, confusion, depression, blurred vision. 2)Cardiovascular system: hypotension, palpitation, syncope. 3)Endocrine: change in libido. 4)Allergic: skin rash. 4/24/2013 JAYESH PATIDAR 86
  • 87. COUNT… 5) Physical/psychological dependence non- benzodiazepines & barbiturate group of drugs has a high risk of abuse & physical dependence. 6) Acute toxicity of barbiturate that can be fetal when taken in excessive dosage usually for suicide attempts. Overdose can cause tachycardia, hypotension, shock, respiratory depression, coma & death. 4/24/2013 JAYESH PATIDAR 87
  • 88. NURSE’S RESPONSIBILITY  Assessment of the patient, prior to the use of antianxiety, sedative-hypnotic agents. If the patient complains of sleep disturbance the causative factor should be identified.  Appropriate nursing measures to induce sleep should be taken such as a calm & quite environment, a cup of hot milk, good back care, allowing the patient to read magazines, sitting with the patient for some time for reassurance purpose.  While administering the drug daily dose should be given at bed time to promote a normal sleep pattern, so that day-time activities are not affected. 4/24/2013 JAYESH PATIDAR 88
  • 89. COUNT…  Give IM injection deep into muscles to prevent irritation.  Look for side-effects, record & report immediately.  If the patient complains of drowsiness tell him to avoid using knife or any other dangerous equipment. He should be instructed not to drive.  Instruct the patient not to take any stimulant like coffee, alcohol as they alter the effect of drugs.  Avoid excessive use of these drugs to prevent the onset of substance abuse or addiction.  Drug should be reduced gradually, sudden stoppage of the drug may cause REM (Rapid Eye Movements), insomnia, dreams or nighmare, hyperexcitability, agitation or convulsions. 4/24/2013 JAYESH PATIDAR 89
  • 91. DESCRIPTION • Antiparkinsonian agents are the specific drugs to treat the extrapyramidal side- effects of antipsychotic agents. • Side-effects are parkinsonism, akathisia, acute dystonia & tardive dyskinesia. • Anticholinergics, antihistamines & amantidne are used to treat these side- effects. 4/24/2013 JAYESH PATIDAR 91
  • 92. MODE OF ACTION • Anticholinergic drugs block the secretion, thereby reducing the symptoms of akathesia & acute dystonia. It is not effective against tardive dyskinesia. • Antihistamines have effects like anticholinergic drugs. Amantadines are dopamine-releasing agents from central neurons. Studies show that this drug may affect some clients with tardive dyskinesia. 4/24/2013 JAYESH PATIDAR 92
  • 93. INDICATION • Antiparkinsonian drugs are used to treat the extrapyramidal symptoms. 4/24/2013 JAYESH PATIDAR 93
  • 94. CONTRINDICATION • Patient with history of closed angle glaucoma, urinary or intestinal obstruction, hypersensitivity, prostatic hypertrophy, tachycardia are not given these drugs. • The drugs are given with caution to patients with mysthesia gravis, arthesclerosis & chronic respiratory problems. • Anticholinergic drugs: Amantadine is given with caution to patients with renal impairment as most of the medication is excreted through the kidney. 4/24/2013 JAYESH PATIDAR 94
  • 95. CLASSIFICATION CHEMICAL & GENERIC NAME TRADE NAME DOSE RANGE PER DAY mgm/Day FROM OF AVAILABILITY I. Anticholinergic Benztropine Biperiden HCL Hydrochiride Trihexyphenidyl Hydrochiride Procyclidine hydrochiride Cogentin Akinetone Dyskinon Pacitane Parbenz kemadrin 0.5-6.0 2.0-8.0 2.0-12.0 5.0-20mg Tab, injection -do- -do- Tab. Tab. II. Antihistamine Diphenhydramine Benadryl 75-100 Capsule & syrup III. Dopamine Drugs L. Dopa Amantadine Hydrochiride Selegline Carbidopa & L.Dopa. Larodopa Symmetrel Deprenyl Sinemet 2 gms-3gms 100-200gms 5-10mg 10-100mg Tab. Tab . Tab. Tab. 4/24/2013 JAYESH PATIDAR 95
  • 96. SIDE-EFFECTS • Anticholinergic:- Side-effects are dry mouth, flushed, dry skin, blurred vision, photophobia, increased heart rate, constipation, urinary retention, mental confusion & excitement. • Antihistamines:- Side-effects are drowsiness, dizziness, anorexia, nausea, vomiting, euphoria, orthostatic hypotension, weight gain, weakness & tingling of hands. • Amantadine:- Side-effects are mood changes, slurred speech, insomnia, inability to concentrate, dry mouth, livedo reticularis that is a red-blue netlike discolouration of the skin which becomes worse in winter. 4/24/2013 JAYESH PATIDAR 96
  • 97. NURSE’S RESPONSIBILITY  Observation- observation of the patient for side- effects of anti-parkinsonian drugs such as tachycardia, palpitation, sedation, drowsiness & blurred vision.  Maintain an intake output chart in case the patient has urinary retention or constipation.  Encourage adequate intake of fluids & roughage in the diet.  Record vital sign such as B.P., pulse & respiration every four hours.  Advise the patient not to get up quickly from a lying- down position to sitting because of orthostatic hypotension.4/24/2013 JAYESH PATIDAR 97
  • 98. COUNT… Educate the patient not to use hazardous machinery or driving when he is on anticholinergic drugs. Encourage the patient to get his routine eye check-up done for early detection of blurred vision or glaucoma. Record the medicine & side-effects accurately. Report & record any side-effects observed to the physician. 4/24/2013 JAYESH PATIDAR 98
  • 100. 1. CLONIDINE 2. METHYLPHENIDATE (RITALIN):- 4/24/2013 JAYESH PATIDAR 100
  • 102. MECHANISM OF ACTION • Alpha2- adrenergic receptors agonist. • The agonist effects of clonidine on presynaptic alpha 2-adrenergic receptors result in a decrease in the amount of neurotransmitters released from the presynaptic nerve terminals. This decrease serves generally to reset the sympathetic tone at a lower level & to decrease arousal. 4/24/2013 JAYESH PATIDAR 102
  • 103. INDICATION • Control of withdrawal symptoms from opioids. • Tourette‘s disorder • Control of aggressive or hyperactive behavior in children • Autism. 4/24/2013 JAYESH PATIDAR 103
  • 104. DOSAGE • Usual starting dosage is 0.1mg orally twice a day; the dosage can be raised by 0.3 mg a day to an appropriate level. 4/24/2013 JAYESH PATIDAR 104
  • 105. SIDE-EFFECTS • Dry mouth, dryness of eyes, fatigue, irritability, sedation, dizziness, nausea, vomiting, hypotension & constipation. 4/24/2013 JAYESH PATIDAR 105
  • 106. NURSE’S RESPONSIBILITY • Monitor BP, the drug should be withheld if the patient becomes hypotensive. • Advise frequent mouth rinses & good oral hygiene for dry mouth. 4/24/2013 JAYESH PATIDAR 106
  • 108. DESCRIPTION • Methylphenidate , dextroamphetamine & pemoline are sympathominetics. 4/24/2013 JAYESH PATIDAR 108
  • 109. MECHANISM OF ACTION • Sympathomimetics cause the stimulation of alpha & beta-adrenergic receptors directly as agonists & indirectly by stimulating the release of dopamine & norepinephrine from presynaptic terminals. • Dextroamphetamine & methylphenidate are also inhibitors of catecholamine reuptake, especially dopamine reuptake & inhibitors of monoamino oxidase. • The net result of these activities is believed to be the stimulation of the several brain regions. 4/24/2013 JAYESH PATIDAR 109
  • 110. INDICATION • Attention-deficit hyperactivity disorder • Narcolepsy • Depressive disorders • Obesity 4/24/2013 JAYESH PATIDAR 110
  • 111. DOSAGE • Starting dose is 5-10 mg per day orally, maximum daily dose is 80mg/day. 4/24/2013 JAYESH PATIDAR 111
  • 112. SIDE-EFFECTS • Anorexia or dyspepsia, weight loss, slowed growth, dizziness, insomnia or nightmares, dysphoric mood, tics & psychosis. 4/24/2013 JAYESH PATIDAR 112
  • 113. NURSE’S RESPONSIBILITY • Assess mental status for chang in mood, level of activity, degree of stimulation & aggressiveness. • Ensure that the patient is protected from injury. • Keep stimuli low & environment as quiet as possible to discourage over stimulation. • To decrease anorexia, the medication may be administered immediately after meals. The patient should be weighed regularly during hospitalization & at home while on therapy with CNS stimulants, due to the potential for anorexia/ weight loss & temporary interruptions of growth & development. 4/24/2013 JAYESH PATIDAR 113
  • 114. COUNT… • To prevent insomnia administer last dose at least 6 hours before bedtime. • In children with behavioral disorders a drug ‗holiday‘ should be attempted periodically under the direction of the physician to determine effectiveness of the medication & the need for continuation. • Ensure that parents are aware of the delayed effects of Ritalin. Therapeutic response may not seen for 2-4 weeks; the drug should not be discontinued for lack of immediate results. 4/24/2013 JAYESH PATIDAR 114
  • 115. COUNT… • Inform parents that OTC (over-the-counter) medications should be avoided while the child is on stimulant medication. Some OTC medications, particularly cold & hay fever preparation contain certain sympathomimetic agents that could compound the effects of the stimulants & create drug interactions that may be toxic to the child. • Ensure that parents are aware that the drug should not be withdraw abruptly. Withdrawal should be gradual & under the direction of the physician. 4/24/2013 JAYESH PATIDAR 115